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Abstract 
 
The development of in vitro culture systems, comparable to the in vivo microenvironment 
in terms of effect on the oocyte growth and development could provide a valuable 
experimental tool for studying the mechanisms governing folliculogenesis. This tool might 
serve as well for practical clinical, agricultural, zoological, or biotechnological applications.  
This thesis reports on the importance of the microenvironment for the ovarian 
folliculogenesis process. The complexity of such a microenvironment was approached with 
a strategy based on functionalized PEG-hydrogels. The PEG matrix not only served as a 
scaffold, but it was also used a “reservoir” of immobilized cues. Tethered integrin-binding 
peptides in combination with other signaling factors aimed at better understanding the 
interactions of the oocyte and its surrounding granulosa cells that, most probably, 
determine the efficiency of the actual and the future in vitro mature oocyte production 
strategies. This work led also to investigating the lymph angiogenesis and the lymphatic 
transport in the context of oocyte maturation and their impact on mice fertility.  
In a first step, the mechanical properties of PEG-hydrogel were optimized for culturing 
secondary follicles. This report shows that the growth of the follicles was highly dependent 
on the mechanical properties of the surrounding environment. The optimal elastic modulus 
was found to be close to 900 Pa. In a second step, the effect of Arg-Gly-Asp (RGD) peptide, 
the minimal integrin-binding sequence, was studied. RGD presence did not influence the 
follicle growth rate but it significantly improved the quality of the produced oocytes. These 
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findings demonstrated that approaching, biochemically and mechanically, the complexity 
of the ovarian extracellular matrix could be a winning strategy.  
The effect of key soluble factors was also investigated in order 1- to confirm their 
compatibility with the established 3-D culture system and 2- to further improve 
qualitatively and quantitatively the produced mature oocytes. Various combinations of 
gonadotropins such as the follicle-stimulating hormone (FSH) or the luteinizing hormone 
(LH) were tested. Interestingly, the effects of the gonadotropins in the 3-D PEG system 
were close to their known effects in vivo. Here the aberrant effects of these hormones in the 
used 2-D systems appeared clearly. 
c-Kit ligand (KL) is suspected to be one of the most important factors for the activation of 
primordial follicles and thus for controlling the exit from the resting pool. Previously, 
studying the effects of the two forms of KL (soluble and membrane-attached) had to cope 
with the lack of biologically-relevant immobilization strategies. For overcoming this 
problem, KL constructs were designed to include a substrate sequence for Factor XIIIa 
(NQEQVSPL or NQEQVSPLRCG). Thus the produced recombinant KL proteins could be 
enzymatically crosslinked to the PEG matrix. The different constructs of KL, including a 
wild type extracellular domain, were successfully cloned and produced from mammalian 
HEK-293 cells. The identity and the activity of the produced proteins were confirmed. 
Ovarian tissues from four days-old mice were cultured in PEG-hydrogels functionalized 
with KL. The results showed that the primordial follicles grew and were activated in the 
PEG-hydrogels where KL was immobilized but not when the soluble form of KL was 
preset in the medium. This experiment showed that the membrane-attached and the soluble 
form of KL play a different role in the rodent folliculogenesis.  
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In parallel it was observed that blocking vascular endothelial growth factor receptor-3 
(VEGFR-3) signaling had a critical but still unsuspected role in reproduction. This study 
demonstrates that variation in lymphangiogenesis is a regular, non-pathological event 
during folliculogenesis in the ovary; blocking lymphangiogenesis, might have an effect on 
hormone transport and thus on pregnancy. The reported results demonstrates that the 
blockade of lymphangiogenesis decreases the progesterone and estradioal levels during 
pregnancy and in fine results in failed fetal development. 
In conclusion, this study demonstrates the efficiency and the flexibility of a novel 3-D 
culture system. Circumventing problems inherent to the “on-plastic” standard culture, such 
as the loss of the granulosa-oocyte interactions, allowed the emergence of a culture system 
tailored for investigating fundamental folliculogenesis-related questions. Furthermore, the 
reported culture system might serve as a platform for developing clinical and biotechnology 
applications.   
 
 
 
 
 
Keywords: folliculogenesis, follicle, primordial follicle, PEG-hydrogel, FactorXIIIa 
substrate, extracellular matrix, c-Kit, c-Kit ligand, lymphangiogenesis, VEGFR-3 
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Résumé 
Le développement d’un système de culture in vitro dans lequel le développement des 
oocytes s’approcherait de ce qui est observable in vivo constituerait un outil expérimental 
décisif  pour la compréhension des mécanismes gouvernants à la folliculogenèse. Il est 
aussi envisageable qu’un tel outil puisse, tout aussi bien, être employé au profit 
d’applications cliniques, zoologiques ou encore biotechnologiques. Le présent document 
apporte une nouvelle preuve de l’importance du microenvironnement ovarien pour la 
folliculogenèse. La complexité d’un tel microenvironnement a été abordée en utilisant un 
système de culture en hydrogels à base de PEG. Ce substrat artificiel n’a pas seulement 
servi en temps que structure de maintiens tridimensionnelle mais aussi en temps que 
« réservoir à signaux ». En effet l’immobilisation de peptides contenants la séquence 
minimale d’attachement aux integrines (RGD), ainsi que d’autres signaux, a permis 
d’étudier les interactions oocytes-granulosa qui déterminent certainement la quantité et la 
qualité des oocytes matures produits par les systèmes de culture in vitro actuels et à venir. 
Par ailleurs, ce travail a aussi abordé les transports lymphatiques et la lymphangiogénese 
ainsi que leurs influences sur la fertilité.  
Dans un premier temps, les propriétés mécaniques des hydrogels employés ont été 
optimisées pour la culture de follicules secondaires. Ce travail établis que le développement 
des follicules secondaires dépend largement des propriétés mécaniques du milieu 
environnent et que l’élasticité optimale semble être située autour de 900 Pa. De même, ce 
travail démontre que la présence de RGD à des concentrations variables ne semble pas 
influer sur la croissance des follicules secondaires mais que par ailleurs, la présence de ce 
peptide améliore significativement la qualité des oocytes produits.  Ces résultats 
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démontrent que mimer biochimiquement et mécaniquement le microenvironnement ovarien 
peut constituer une stratégie efficace. 
Dan un deuxième temps, l’effet de certain éléments solubles a aussi été étudié 1- pour 
confirmer leur activité dans le système hydrogel  et 2- pour améliorer qualitativement et 
quantitativement les oocytes matures produits. Diverses combinaisons de gonadotrophines 
(FSH et LH) ont été testées. Les effets observés de ces hormones dans le système hydrogel 
sont relativement proches des effets observés in vivo. Ceci souligne ici l’effet aberrant que 
ces hormones peuvent avoir dans les systèmes de culture bidimensionnels. 
Les ligands des récepteurs c-Kit (KL) semblent jouer un rôle important dans l’activation 
des follicules primordiaux et donc de leur sortie de la phase de dormance. Les études 
précédentes voulant étudier l’effet des deux formes de KL (soluble ou encrée à la 
membrane) on dues composer avec l’absence de stratégies d’immobilisation biocompatible. 
Pour résoudre ce problème, des protéines fusionnées à une séquence-substrat du facteur 
XIIIa (coagulation) ont été produites. Ces dernières on put ainsi être immobilisées 
enzymatiquement sur hydrogel. Les différentes protéines recombinantes on put être 
produites par des cellules HEK-293 (mammifère). La conformité de leurs séquences ainsi 
que leur bioactivité ont été confirmé. Des tissue ovarien récoltés sur des animaux âgés de 
quatre jours on été mis en culture dans des hydrogels où différentes formes et 
concentrations de KL furent préalablement immobilisées. Il a ainsi put être démontré que 
les oocytes primordiaux ont été activés où seule la forme ancrée de KL était présente.   
Parallèlement, il a été observé que le blocage de la voie de signalisation passant par 
VEGFR-3 a un effet drastique mais encore non documenté sur la reproduction. Ce travail 
démontre que la régulation de la lymphangiogenèse dans l’ovaire est un phénomène naturel 
non pathologique et qui est concomitant à la folliculogenèse. Le blocage de la formation de 
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vaisseaux lymphatiques peut avoir un effet sur le transport des hormones et donc sur la 
fertilité. Les résultats présentés démontrent qu’en absence de lymphangiogenèse les taux de 
progestérone et d’œstradiol décroissent pendant la grossesse aboutissant in fine à 
l’avortement.   
Les résultats de ce travail démontrent l’efficacité et la flexibilité du système de culture en 
hydrogel établis. Le contournement des problèmes inhérents à la culture standard  en boite 
de Petri, tel que la perte du contact oocyte-granulosa, a permit l’émergence d’un système de 
culture à même de servir à l’étude des mécanismes sous-tendant  la folliculogenèse. De plus 
ce nouveau système de culture pourrait servir d’ébauche pour le développement de 
plateformes à usage clinique ou biotechnologique. 
Mots-clés: folliculogénèse, follicule, follicule primordial, PEG-hydrogel, FactorXIIIa, 
matrice  extracellulaire, c-Kit, ligand c-Kit, Lymphangiogénèse, VEGFR-3 
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Abbreviations 
 
cAMP Cyclic adenosin monophosphate  
BMP-15 Bone morphogenetic protein-15  
ECM Extra cellular matrix 
EGF Epidermal growth factor human  
FBS Fetal bovine serum  
FSH Follicle-stimulating hormone 
GDF-9 Growth differentiation factor 9  
GV Germinal vesicle  
GVBD Germinal vesicle breaks down  
HBSS Hank’s buffered salt solution 
HCG Human chorionic gonadatropin  
ITS The mixuture of 5 µg/mL insulin, 5 µg/mL transferrin, and 5 ng/mL selenite 
KL c-Kit ligand  
LECs Lymphatic endothelial cells  
LH Luteinizing hormone 
LHR Luteinizing hormone receptor 
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LIF Leukemia inhibitory factor 
L15 Leibovitz medium 
α-MEM α-Minimal essential medium  
MII Methaphase II  
MGF Mast cell growth factor 
MMPs Matrix metalloproteinases   
PEG Polyethylene glycol 
PEG-VS PEG vinyl sulfone  
P/S 100 IU/mL penicillin and 100 µg/mL streptomycin  
RGD Arg-Gly-Asp 
SAMS Swiss academy of medical science 
SCF Stem cells factor   
SCNAT Swiss academy of sciences  
SF Steel factor  
VEGF Vascular endothelial growth factor  
VEGFR-3 Vascular endothelial growth factor receptor-3  
VS Vinyl sulfone 
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Chapter I:  
 
Overview and general introduction 
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1.1. Overview  
Primordial follicles are the earliest form of ovarian follicle and consist of primary oocytes 
surrounded by a single layer of flattened pre-granulosa cells. There are thousands of 
primordial follicles present in the neonatal mammal’s ovaries [1, 2]. Primordial follicles 
can be considered as the storage form of the ovarian follicles and constitute a potentially 
valuable source of oocytes that could be used for clinical, agricultural, and zoological 
purposes [3-5]. To be fully functional, an oocyte has to accomplish the following: A 
nuclear maturation, including completion of the meiotic division. A cytoplasmic maturation 
must be accomplished for the accumulation of maternal factor gene products essential for 
supporting fertilization and early embryogenesis. An epigenetic maturation must be 
accomplished, including genomic imprinting [5].  Thus, it is a considerable challenge to 
achieve full oocyte development in vitro. 
During last decade, several culture systems have been developed allowing the growth of 
rodent oocytes in vitro from secondary follicle [6-9]. Oocytes recovered from these culture 
systems can be fertilized, and live young can be obtained [8]. However, approaches for 
recovery and reproducible in vitro development of primordial follicles to maturity, in which 
oocytes acquire complete competence to undergo maturation, fertilization, and embryonic 
development, are still needed. More recently, two groups reported the possibility to produce 
a maturated mouse oocyte from a primordial follicle [3-5]. These achievements used a 
complex and poorly characterized two-step procedure involving organ culture in vitro [5] 
or in vivo grafting [3, 4] for primordial follicles to begin growing, followed by isolation of 
the growing follicles.  
The medical needs of methods for follicular maturation are substantial. Ovaries are 
especially sensitive to cytotoxic treatments, alkylating agents and ionizing radiation, 
generally resulting in loss of both endocrine and reproductive function [10]. While not all 
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chemotherapy causes women patients to become infertile, the effects vary with drugs, doses, 
and individual sensitivities; many regimens do result in loss of fertility. Fertilized eggs 
survive freezing and thawing better than unfertilized ones, consequently the best chances of 
success come from in vitro fertilization (IVF). Generally, a woman undergoing this 
procedure before having chemotherapy is treated with hormones in order to superovulate. 
The oocytes are subsequently fertilized with sperm from the partner or a donor and 
conserved frozen. In many cases, eggs cannot be harvested because the patient might be too 
young, the type of cancer might exclude a hormonal treatment causing superovulation, or 
the patient might need to start treatment immediately because of the aggressiveness of the 
cancer [5, 10]. For patients under those circumstances, cryopreservation of ovarian tissue 
might be a possible alternative. Transplantation of ovarian tissue is a possibility, but rises 
the question of re-transferring the cancer cells to the patient [5, 10]. A single report 
appeared in 2004 [10] describing a cancer survivor (32-year-old) who became infertile after 
chemotherapy and gave birth after ovarian tissue removal, freezing and reimplantation. 
This report mentioned that the loss of primordial follicles in cryopreserved ovarian tissue 
after transplantation is estimated to be more than 50 % due to hypoxia. Moreover, it is 
difficult to say that only primordial follicle of the grafted tissue contributed for giving a 
birth, because the biopsy samples indicated not only survival of primordial follicles in 
grafted tissue but also follicular maturation [10].  
The development of an efficient cell culture system could also have a profound effect on 
the treatment options of infertile couples by avoiding the need for intensive drug treatment 
and repeated egg collection, as several hundred follicles at early stages could potentially be 
recovered in a small ovarian biopsy, even from young ovaries. Additionally, in vitro growth 
of follicles together with in vitro maturation of fully-grown oocytes could be used to 
generate sufficient oocytes for the needs of patients and provide spare oocytes for donation 
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or research purposes. The combined technologies of ovarian tissue cryopreservation as well 
as growth and maturation of oocytes in vitro could also help young cancer patients to 
preserve their fertility through the storage of their own germ cells before aggressive chemo-
or radio-therapy [11].  
In the last decade, the studies of in vitro maturation of oocytes aimed at better 
understanding the underlying mechanisms of oocyte growth and maturation [1, 2, 8, 9, 12]. 
One of the difficulties in the in vitro cultivation of these very early follicles is the 
prevention of pre-granulosa cells from migrating away from the oocyte and in so doing 
breaking the metabolic link between the two cellular compartments causing apoptosis of 
the oocytes [6]. In nature, when follicles leave the resting pool they undergo a primordial-
to-primary follicle transition and the surrounding squamous pre-granulosa cells become 
cubical granulosa cells and begin to proliferate. Several growth factors have been identified 
to act locally within the ovary and to be involved in the regulation of primordial-to-primary 
follicle transition such as bone morphogenetic protein-15 (BMP-15, produced by the oocyte 
and stimulating the granulosa cells) [13, 14], leukemia inhibitory factor (LIF) [15], and c-
Kit ligand (KL, produced by the granulosa cells and stimulating the oocyte) [14-17]. KL 
was shown to participate in a feed-back loop, where it enhances the expression of KL by 
BMP-15, which as consequence stimulates granulosa cells proliferation [14]. As follicles 
continue to develop through the primary, secondary and pre-antral stages they gain 
successive layers of granulosa cells, the oocyte increases in size and theca cells surround 
the follicle.   
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1.2. Objectives 
Our overall objective it so develop a culture system that is more robust and that takes over 
some of the figures of the regulatory cycle described above.  Our aim is to explore the 
effect of a three-dimensional and functionalized hydrogel network (made of polyethylene 
glycol) on the in vitro follicle development.  
The study will aim at answering the following questions: 
1- Can we mimic the biomechanical effects of the ovarian tissues and maturate oocytes in 
an artificial 3-D environment?  
2- Can we elucidate the gonadotrpoin-mediated (FSH and LH) regulation during follicle 
growth in an artificial microenvironment (hydrogel)? 
3- Is KL sufficient or are more signals necessary for activating primordial follicles (in the 
PEG-hydrogel culture system)? 
4- Can we bring more insights into the lymphatic transports-fertility relation? 
The current in vitro culture systems are now using pre-antral follicles for initiating cultures 
[3-5]. These isolated secondary follicles are maturated in a drop culture system. This 2D 
culture system obliges the follicle to attach on the bottom of the culture dish. This 
attachment induces the remodeling of the original follicle structure [9]. This remodeling 
leads to confuse hormonal or growth factor effects due to the lost of cell-cell interactions. 
The microenvironment system that we intend to develop will help to better understand 
maturation process by mimicking the ovarian extra cellular matrix (ECM). The used 
crosslinked hydrogel network is composed of hydrophilic polymer chains and as the extra 
cellular matrix (ECM) it is sensitive to proteolitic degradation [18, 19]. The molecular 
structure and composition of the hydrogel allow the transport of macromolecules, which 
may enhance the three dimensional organization of the oocyte. In addition to that, it is 
known that KL plays an important role in the “critical” transition from the primordial to the 
primary stage of the follicle [8, 14, 15, 17, 20]. In this regard, the production and binding to 
the hydrogel of recombinant KL will allow the recapitulation of a microenvironment 
combining the advantages of 3-D culture and KL signaling.  
1.3. Folliculogenesis 
The follicle structure is important to sustain oocyte growth and maturation as a 
morphological and functional unit in the ovary of mammalian species. The follicle is 
basically composed of an oocyte in the center surrounded by granulosa cells and/or theca 
cells. 
 
 
 
 
Fig. 1.1. Small fractions of the original stockpile of primordial follciles are recruited 
throughout the reproductive life, whereas most of primordial follicles remian arrested 
at the initial stage of development. This figure is adapted from Kapia A. & Hsueh 
AJW, Annu. Rev. Phzsiol. 59: 349-363, 1997 
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The initial primordial follicles populate the ovarian cortex and serve as a pool of oocytes 
during the entire reproductive life span [21]. They are quiescent or non-growing or resting 
until their growth is actively initiated. It was observed that the flatten granulosa cells of 
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primordial follicles can occasionally enter the cell cycle [22].  The follicles that entered the 
growth phase do not always continue to grow and the majority will undergo apoptotic 
demise (Fig.1.1) [23].  
Folliculogenesis is the growth process that brings the primordial follicle to a fully-grown 
matured secondary oocyte that is able to be fertilized (Fig.1.2). A large number of 
primordial follicles exist in the ovary, but only few follicles enter the developing phase 
(Table. 1.1). The binging of the growth phase is marked by changes in morphology of the 
granulosa cells that become cuboidal. Follicle with more than two layers of granulosa cells, 
complete zona pellucia and theca cells are called preantral or secondary follicle. When 
these follicles reach 200 µm in the size, fluids are accumulated between the granulosa cells 
layers and form a small single antral cavity. This stage is called antral follicle and is 
characterized by the expression of luteinizing hormone (LH)-receptors in the theca cells.  
The last stage is the preovulatory or graffian follicle which has a big antrum and that is 
ready to ovulate a fully mature oocyte [2, 21]. The different steps of folliculogenesis are 
regulated by various endocrine and paracrine factors such as cytokines, growth factors and 
neuropeptidergic substances. 
 
 
Fig. 1.2. Schematical folliculogenesis of mouse and human. The growth process necessary 
to bring the enclosed small immature primary oocyte to a fully-grown mature secondary 
oocyte, ready to be fertilized, is dependent on the growth and development of the follicular 
structure. This process is called folliculogenesis. 
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Table 1.1. Number of ovarian follicles in mammals. The ovary contains a huge number 
f primordial follicles at the birth, however only few of them reach to developing 
ollicle. 
o
f
 
  * Mean number of pair of ovaries. Miyano,  Reprod. Dev., 51: 169-176, 2005  
 
1.4. Oocyte maturation 
Oocyte maturation is essential for fertilization and support of the early embryo 
development. Maturation can be nuclear or cytoplasmic. Nuclear maturation is referred to 
as the reinitiation of the first meiotic division and the progression to methaphase II (MII) 
[24]. Fig. 1.3 represents the progression of the nuclear maturation. Germinal vesicle (GV) 
characterizes oocytes arrested at prophase I and having a nucleus visible in light 
microscopy. Once the meiosis is resumed, the nuclear envelope is dislocated; it is the 
germinal vesicle breaks down stage (GVBD). The dispersion of nuclear contents in the 
cytoplasm is followed by the chromatin condensation into discrete bivalents that align on 
the meiotic spindle at metha phase I (MI). The bivanlents separation during anaphase and 
telophase I is followed by the methaphase II (MII). MII is recognized by the emission of 
polar bodies. The MII stage is arrested until fertilization happens [25]. Cytoplasmic 
maturation is concomitant to nuclear maturation. This maturation is referred to as the 
processes modifying the oocyte cytoplasm and it involves the production and the presence 
of specific factors, the relocation of cytoplasmic organelles and the post-transcriptional 
modification of mRNAs that have accumulated during oogenesis [24]. Both nuclear and 
cytoplasmic regulations are important to support the entire oocyte maturation process.  
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Fig. 1.3. Schematic diagram representing the progression of  
nuclear maturation. The figure is from Smith, G.D., Current  
Women’s Health Reports, 1:143-151, 2001  
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1.5. In vitro follicle culture systems 
During last few decades, in vitro follicle culture was intensively studied in different 
animals and Human. The mouse is the most studied animal and serves as a model. This is 
mainly due to their short life cycle. Within the first 2-3 weeks after birth, the mice oocytes 
grow from a diameter of 15-20 µm to a final size of 70-75 µm [26].   
Generally the secondary follicles already in the growth phase are chosen for research. The 
secondary follicles can be retrieved from the two week-old mice by enzymatic digestion or 
by mechanical dissection. It has been demonstrated that the proteolytic digestion of the 
interstitial matrix destroys the extracellular matrix between the follicle and the surrounding 
cell layer [27, 28]. Thus, the mechanical isolation method is preferred for the follicle 
culture. In this method, the ovary is dissected with a thin gage syringe and the secondary 
follicles (100-130 µm size) are retrieved without destroying the extracellular matrix. The 
standard follicle culture system consists of single droplets culture. Single follicle are seeded 
in each droplet of medium and covered with mineral oil for preventing evaporation [29]. 
Although, this system gives satisfying results including birth of offspring [30-32], it is 
difficult to study the ovarian physiology in this in vitro system because of the induced 
remodeling and because of the loss of oocyte-granulosa contact. This situation produced 
discrepancies in the literature addressing the in vitro follicular physiology. There were 
efforts to preserve the spherical organization of the follicle by culturing them on collagen 
treated/hydrophobic membranes or in individual V-shape 96-well plates. Here, attachment 
was avoided by daily transferring the follicle to a new well [33-35]. Recently, Pangas, et al. 
[36] demonstrated that the three dimensional (3-D) culture of follicle using alginate bead 
allowed the follicles to grow and developed and to maintain its original structure [37]. 
However, this method was limited by the limited control over the follicle number per bead. 
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Daily microscopic observation and growth factor immobilization were also found 
challenging in this system.  
1.6. Synthetic PEG-based ECM analogs 
The reported synthetic hydrogel system is based on PEG. This system combines self-
selective cross-linking chemistry and rapid gelation in aqueous solution at physiological pH 
and temperature [38, 39]. It is perfectly suitable for maturating oocytes in contrast with 
other synthetic hydrogels that need cross-linking by large doses of γ-radiation, ultraviolet 
light, or high temperatures that may lead to damage the contained material [38]. This 
system exploits novel synthetic schemes, based on Michael-type conjugate addition 
reaction, for the preparation of the tailored interactive network architecture based on PEG 
[18, 19, 38-40]. The PEG-hydrogel forms after the reaction of the end-functionalized PEG 
vinyl sulfone (PEG-SV) with bis-cystine peptides containing protease-sensitive sequences 
under physiological conditions [18, 39, 40]. Due to the used Michael-type addition, the 
reaction is based on thiol structure-reactivity relationship. This system allows to easily 
functionalizing the network with adhesion sites or with receptor or ligand signal site by 
their thiols.  
1.7. c-Kit ligand 
Mutation in the murine locus for c-kit ligand (KL) and its receptor c-Kit induce defects in 
gametogenesis, melanogenesis, or hematopoiesis [41]. KL is referred to as the mast cell 
growth factor (MGF), stem cells factor (SCF) or steel factor (SF). KL signaling is triggered 
upon recognition of the ligand and after activating the type III tryrosine kinase receptor: c-
Kit (Fig.1.4) [42].  
 
 
F
 
ig. 1.4. Binding of KL on c-Kit and consecutive activation. 
 
The ovarian expression pattern of KL and c-Kit mRNA and protein was established in 
primates and humans [43-45], sheep [46], and rodents [47, 48]. KL is expressed in the 
granulosa cells and in the ovarian epithelial cells while c-Kit is expressed in primordial 
germ cells, theca cells and oocytes [49]. The interaction of KL and c-Kit was reported to be 
important for primordial follicle activation, thus inducing the exit from the resting pool and 
the entrance in the growth phase [50, 51]. It was confirmed that KL could promote 
granulosa cell mitogenesis. However, another unknown signals from the oocyte are 
necessary to mediate the proliferation [14]. Growth differentiation factor 9 (GDF-9) [52] 
and bone morphogenetic factor 15 (BMP-15) [13] were suggested as candidates. KL was 
suggested to be involved in promoting the survival of both primordial [53] and secondary 
follicle [50]. Often contradictory results are published regarding the effect of KL on 
primordial follicle survival.  
1.8. Lymphangiogenesis 
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Lymphangiogenesis is the growth of new lymphatic vessels. It is modulated by many of the 
lymphatic molecules. The molecules involved in developmental lymphangiogenesis are 
different from those considered in lymphangiogenesis in the adult associated or those 
associated with wound healing or tumor growth and metastasis [54]. The most widely 
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studied growth factors driving lymphangiogenesis are members of the vascular endothelial 
growth factor (VEGF) family. VEGF-C and –D were identified and characterized by 
investigating the lymphatics in tumor progression and by the search for potential 
lymphangiogenic therapies in lymphedema [55]. Growth factors are essential for the 
proliferation and migration of lymphatic endothelial cells (LECs) [56]. When the primary 
receptor, VEGFR-3 is blocked it inhibits lymphangiogenesis in healing wounds [56, 57], 
inflammation [58, 59], and prevents tumor metastasis [60].  
1.9. Guiding thread  
Along the four chapters of this thesis we tried to establish a new 3-D in vitro culture system 
for maturing oocytes. The developed system was based on PEG-hydrogel. The main idea 
was to approach and reconstruct a part of the complexity of the natural microenvironment 
in which maturation of the oocyte occurs: the ovarian tissue and its ECM. This 
microenvironment was assumed to have four major type of influence on folliculogenesis: I. 
biomechanical, II. soluble compounds and hormonal signalling, III. tethered signalling 
proteins and IV. lymphatic related. Each chapter of the thesis tried to go deeper in the 
understanding of these mechanisms. 
In vivo, the first role of the ECM is purely mechanical. It determines the tissue rigidly 
and/or elastically. Moreover, ECM components such as fibronectin are not only playing a 
structural role; they can trigger biological responses such as cell attachment [61]. In this 
regard we tried, in the first chapter, to find the most relevant rheological properties of the 
culture system. The biochemical roles of ECM were investigated by studying the effects of 
the minimal peptide that mediates cell attachment (RGD).  
The ECM can also be seen as a filter that interacts with different compounds in solution 
within the ovarian tissue. It was reported as playing a major role for the hormonal balance 
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in vivo. However when it comes to 2-D culture systems, an abundant and controversial 
literature exists. This controversy is often linked to the lack of ECM in these studies. This 
aspect of the ECM was investigated in chapter II. There we tried to investigate the complex 
relation hormones-ECM. There, the effects of two soluble factors (FSH & LH) on 
secondary follicles development and oocyte maturation were studied.  
In the third chapter the efforts to reconstruct the ovarian tissue environment continued with 
investigating the effect a tethered signaling factor that is important for folliculogenesis: c-
Kit ligand (KL). KL was a very good model system as its bioactivity (for folliculogenesis) 
is closely linked to its immobilization. There, recombinant KL with different 
immobilization strategies (compatible with our hydrogel system) was produced. 
Immobilization of rKL was achieved and preliminary experiments were processed with 
mice ovarian tissue. 
Chapter four investigated lymphangiogensis in the ovary as, ultimately, the reconstruction 
of an efficient artificial ovarian tissue needs to embed the features of a vascular system. 
Numerous studies dealt with angiogenesis and reproduction. However, little is known about 
lymphangiogenesis in the ovarian tissue. In this chapter we were the first to describe the 
abundant lymphatic vasculatures in the ovary and the importance of lymphangiogenesis 
during follicles growth. This work demonstrated that the success of future artificial ovarian 
tissues will largely depend on their ability to include complex transport mechanisms such 
as lymphangiogenesis. 
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Chapter II 
 
Optimization of the biophysical properties of 
PEG-hydrogels for murine ovarian follicle culture  
28 
 
 
2.1. Introduction 
The extracellular matrix (ECM) has many different functions; 1-Mechanically, it gives the 
tissues rigidly and/or elastically. 2-Chemically, it contains many cues that modulate the 
cellular activities. These properties are essential to the basic cellular activities that are, 
differentiation, migration, proliferation, apoptosis, attachment, etc [62, 63]. ECM is also 
playing an important role in the regulation of the interstitial flow by generating osmotic 
forces, or by filtering materials from solutions [62]. From the ECM point of view, the 
mammalian ovary is a special organ because it undergoes cyclical ECM remodeling. This 
remodeling is caused by the follicular development, atresia, and the breakdown of the 
follicle wall at the time of ovulation, the luteal formation and subsequent regression [64].  
For the ovulation of a matured oocyte to occur, primordial follicles as an initial stage must 
develop into large antral follicle (called graffian follicle), which is ready to ovulate. During 
this process, the size of the oocyte increases about 100-folds [26]. The ovarian ECM 
supports the follicle structure and generates osmotic forces for follicular fluid formation 
and filtering soluble materials through the follicular basal lamina, transfers the hormone 
and nutrients, and cyclic remodeling [63]. It has been reported that the remodeling of the 
ovarian ECM is related to matrix metalloproteinases (MMPs) activity [64-66] and to 
integrin-binding activity of adhesive factors, such as fibronectin, (or synthetic peptide 
containing Arg-Gly-Asp sequences). This remodeling has been shown to favor both 
proliferation and differentiation of granulosa cell [67].  
Two-dimensional culture systems routinely used for follicle culture induce remodeling of 
the follicles structure as the granulosa cells are migrating away from oocyte. This 
remodeling is necessary for getting better oxygenation, nutrients, and access of hormone 
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support to the inner most follicle cells [68]. An abundant literature dealing with in vitro 
follicle culture has been produced. The effects of the most important growth factors and 
hormones on the development of ovarian follicles were described for in vitro systems. 
However, the underlying mechanisms by which the ovarian ECM controls of the follicular 
growth and development remains poorly understood.  
So it is necessary to develop in vitro culture systems to mimic the in vivo follicle 
environment. The development of biomimetic follicle’s microenvironments will be useful 
for understanding the ovarian ECM, identifying the mechanical mechanisms underlying 
ovarian disorders such as polycystic ovary syndrome, and preservation reproductive 
potential for infertility couple and cancer patients.  
Mimicking the ovarian ECM requires several conditions; first, maintaining the three-
dimensional structure of the follicles is essential. Second, the matrix should be cell 
responsive, as it has to be remodeled for allowing the follicles to grow. Third, the artificial 
ECM must be easily functionalized with signaling elements such as integrin binding 
proteins or growth factors. Finally, artificial ECM must allow single follicle culture and 
must be compatible with daily microscopical observation during follicle growth.  
The 3D culture system was first introduced to follicle culture by using alginate gel [36]. In 
this system, the follicles grew and developed without losing the typical morphology of in 
vivo grown-follicles. However, this system was limited by the difficulty to control single 
cell culture and to observe the growth process because of the beads shape. Immobilizing 
signaling factors was also limited in the alginate bead culture system.  
The goal of this study is to demonstrate the importance of the interactions between the 
ECM and the follicle in the maturation process of the oocyte. The used PEG based 
hydrogel system was chosen for several reasons:  
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1- It adds the 3rd dimension that is missing to the culture on plastic systems. 2- It has 
comparable rheological properties (elastic modulus) when compared to ovarian tissues. 3- 
It is cell-responsive, as it allows the cells to remodel their 3-D environment by MMP 
secretion 4- Key signaling factors can be efficiently tethered to activate specific pathways 
and thus mediate the desired biological function [40]. 
2.2. Materials and Methods 
2.2.1. Animals  
Female F1 hybrid (C57BL/6 x CBA/caj) mice bred and housed in temperature-, lighting-, 
and humidity-controlled room and given food and water ad libidum. All animal 
experimental procedures were approved by the veterinary authorities of the canton de Vaud 
in accordance with the Swiss Academy of Medical Science (SAMS) and the Swiss 
Academy of Sciences (SCNAT) guidelines.  
2.2.2. Synthesis of PEG-VS and peptide precursors  
PEG vinyl sulfone (PEG-VS) was synthesized by adapting a previously published protocol 
[18]. Briefly, 15 g of 4-arm PEG-OH (Mw = 20 kDa, Shearwater polymer, Huntsville, AL) 
was dried by azeotropic distillation in toluene (VWR, Nyon, Switzerland) for 4 hr using a 
Dean-Stark. The dried PEG-OH was dissolved in 500 mL of dichloromethane (Fisher 
Scientific, Wohlen, Switzerland) and sodium hydride (Sigma-Aldrich, Buchs, Switzerland) 
was added at 20-fold molar excess over OH-group of PEG. Then, divinyl sulfone (Fluka, 
Buchs, Switzerland) was added at a 50-fold molar excess over the OH groups. This reaction 
was carried out at room temperature under argon with constant stirring. After 3 days, the 
excess sodium hydride was neutralized by acetic acid (Fluka, Buchs, Switzerland). The 
mixture was filtered over a filter cell cake and concentrated by rotary evaporation. The 
concentrated polymer was precipitated in ice-cold diethylether (Brunschwig, Basel, 
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Switzerland) and filtered. This precipitation was repeated 3 times. Finally, the product was 
dried under vacuum at room temperature for three days and the yield was 82 %. 1H NMR 
showed characteristic vinyl sulfone peaks at 6.1, 6.4, and 6.8 ppm. The degree of end-group 
conversion was found to be 95 %. The polymer was stored under argon at -20 °C until used. 
The procedure was reviewed in detailed by Kraehenbuehl et al. (2008) [69].   
RGDSP peptide (Ac-GCGWGRGDSPG-NH2) was synthesized by solid phase peptide 
synthesis using an automated peptide synthesizer (Chemspeed, Augst, Switzerland). 
NovaSyn TGR resin (Merck Biosciences, Laeufelfingen, Switzerland) with a standard 
Fmoc chemistry was used. Purification was performed by mass-directed reverse phase-C18 
HPLC using a Water Autopurification System. Separation and collection of the samples 
were performed upon UV with broad wavelength detection (210-400 nm) (Water PDA 996 
UV photodiode array) and mass directed software (Waters Masslynx software). Peptide 
sequences were confirmed by MALDI-TOF in the proteomics core facility of EPFL.  
The cross-linking peptide that contains a sequence sensitive to MMP cleavage (Ac-
GCREGPQG↓IWGQERCG-NH2) was obtained from Neosystm S.A. (Strasboug, France).  
2.2.3. Formation and characterization of the PEG-hydrogels 
The PEG-hydrogels were formed by Michael-type addition of thiol-containing peptides 
onto VS-functionalized PEG. First, the PEG-VS necessary for forming hydrogels was 
functionalized with arginine-glycine-aspartic acid (RGD) peptides (also by Michael-type 
addition). Thirty-nine µL of 10 % PEG hydrogel (in TBS pH 8) solution were mixed with 
6 µL of a 400 µM RGDSP peptide solution (in H2O). The addition proceeded at room 
temperature for 30 min. Second, 15 µL of medium containing or not cells, was added into 
the RGD reacted with PEG-VS solution. Finally the gel polymerization was initiated by 
adding 1.24 mg of the cross-linker peptide dissolved in 24 µL of triethanolamine buffer 
32 
 
(TEOA, 0.3 M, pH8.0; Fluka, Buchs, Switzerland). Before curing, drops of 28 µL of 
hydrogel solution were placed between two hydrophobic glass slides separated by a 1 mm 
spacer and pretreated with SigmaCote (Sigma-Aldrich, Buchs, Switzerland). The slides 
were fixed with clamps and the whole system was put in an incubator (37°C, 5% CO2) for 
18 min to polymerize. For characterization, the prepared gels were incubated overnight at 
37 °C in bidistilled water. The swelling of the hydrogels was investigated by weighing the 
gels after the overnight incubation in water. The swelling ratio Q was determined as the 
swollen gel mass divided by the gel’s dry mass. 
The swollen gels were also used to measure storage and loss moduli (G' and G" 
respectively) by small-strain oscillatory shear rheometry using a Bohlin CVO 120 high-
resolution rheometer (Marvern Instruments, Worcestershire, UK). Measurements were 
performed at 25 °C. Storage and loss moduli, as wheel as phase angle, were measured as a 
function of frequency (from 0.1 to 10 Hz) in a constant stain mode (0.05 Hz). The swollen 
hydrogel disks of 1-1.4 mm thickness were placed between the two plates of the rheometer. 
Compression of 70 to 75 % was applied to avoid slippage. 
2. 2.4. Follicle isolation, seeding and culture 
Ovaries were collected from two-week old F1 female mice (C57BL/6 x CBA) after 
euthanasia by cervical dislocation. The collected ovaries were washed with HBSS (Hank’s 
buffered salt solution, Gibco-Invitrogen, Switzerland) and placed in L15 (Leibovitz 
medium, Gibco-Invitrogen, Switzerland) supplemented with 10 % heat-inactivated FBS 
(fetal bovine serum, Hyclone), 100 IU/mL penicillin and 100 µg/mL streptomycin (P/S). 
The ovaries were mechanically dissected using insulin syringe.  Only follicles with two 
layers of granulosa cells (100-120 µm) were collected using a mouth-operated micropipette 
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[70]. The follicles were washed and kept in L15 washing droplets covered by paraffin oil 
(Vitrolife, Sweden).   
The follicle were seeded in the above described hydrogel system. Six µL hydrogel drops, 
containing a unique follicle were formed. After curing, each of these gels was placed in a 
well of a 96 wells-plate, 150 µL of culture medium was added.  
The culture medium consisted of α-minimal essential medium (α-MEM  with glutamax, 
Gibco) supplemented with 5 % FBS, ITS (5 µg/mL insulin, 5 µg/mL transferrin, 5 ng/mL 
selenite, Sigma, Buchs, Switzerland), 1 % of P/S, 100 mIU/mL of recombinant follicle 
stimulating hormone (rFSH, Organon, Switzerland). Next day, the medium was changed 
completely with fresh medium. Every second day, half of the medium was replaced with 
fresh one.  
2.2.5. Oocyte maturation and quality assessment  
The oocytes meiotic competences were assessed by induced maturation after 11 days of 
culture. The grown follicles were retrieved from gels by incubating the gels in a 5 mg/mL 
collagenase I solution (Sigma, Buchs, Switzerland). The follicles were moved to culture 
medium with 5 ng/mL of human epidermal growth factor (EGF, Roche, Basel, Switzerland) 
and 2.5 IU/mL of human chorionic gonadatropin (HCG, Organon, Switzerland) without 
rFSH and incubated at 37 °C for 18-20 hrs to induce the ovulation. After the induction of 
the ovulation, oocytes were removed from the cumulus oocyte complex or the follicle by 
using a mouth-operated micropipette. The collected oocytes were washed in M2 medium 
(Sigma, Buchs, Switzerland) droplets and their state was assessed under stereomicroscope 
and characterized as DG (degenerated), GV (intact germinal vesicle), or GVBD (germinal 
vesicle breakdown) based on the presence or the absence of a germinal vesicle and MII 
(metaphase II) due to the presence of polar body.  
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Parthenogenesis was induced by 10 mM strontiumchloride in Ca2+ free KOSM medium 
with 1 µg/mL of cytochalasin D. After 4 hr, the oocytes were moved to M16 medium and 
two-cell embryos were observed one or two days later. 
2.2.6. Statistic analysis 
The statistical analysis of the data was performed with the program OriginPro 8.0 
(Originlab corporation, MA, USA). Significances at p< 0.001, p<0.01 and p<0.05 (***, ** 
and * respectively) of the differences were assessed with a T test.  
2.3. Results and discussion 
2.3.1. PEG-hydrogel physical properties 
A wide variability in term of mechanical properties can be measured across the different 
mammalian tissues. For example, the softest tissue: the brain has an elastic modulus (G’) of 
200-400 Pa [71]. G’ of the bones (the hardest tissue) is more than 17 GPa [72]. The first 
step of this study was to investigate the effect of different stiffness on the follicle 
development. Thus, the mechanical properties and the swelling ratios of the PEG-hydrogel 
were modulated by controlling the crosslinks density. The hydrogel networks were formed 
with 4-arm-PEG-VS, (20 kDa) and bis-Cys crosslinking peptide with an MMP cleavage 
site. The effect on G’ of four different stoichiometric ratios (r equals the molar ratio of SH 
and VS groups) were investigated (Fig. 2.1). A large variation in stiffness was obtained and 
a linear relatio between r and G’ was observed. At the lowest stoichiometric ration the 
hydrogels had a mean G’ of 291±87.64 Pa and at the highest, G’ was 2.277 ± 0.47 kPa. 
Swelling was also influenced by the stoichiometric ratios. The highest swelling ratios (Q = 
75.57 ± 7.02) was obtained for the lowest r = 0.8. A clear negative correlation between 
swelling and elastic modulus was observed. These measured mechanical and swelling 
properties are in accordance with previous reports [18, 19] that characterized the PEG-
Hydrogel systems.  
 
 
Fig. 2.1. Elastic modulus and swelling properties of the PEG-
hydrogel as a function of the stoichiometric ratio. The density of the 
crosslink was modulated by four different stoichiometric ratios 
(SH/VS). Elastic modulus G’ (left axis) and Swelling ratio Q (right 
axis) were measured. Mean ± SD is shown. The swelling ratio and 
elastic modulus were negatively correlated. 
 
2.3.2. Follicle growth in PEG-hydrogels and oocytes quality 
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Two-layered secondary follicles at 100-120 µm sizes were collected and seeded 
individually into each PEG-hydrogel functionalized with RGD peptides. Overall, more than 
400 secondary follicles were cultured for 11 days in all the different PEG-hydrogel systems. 
Fig. 2.2 shows that the size of the follicles was greatly increased in the gel with less than 1 
kPa of elastic modulus (r = 0.8 and 0.9) after 11 days of culture. In the stiffest gels (r=1.5) 
follicle growth was limited to 200 µm.  Surprisingly, at identical swelling ratios but 
different G’ (r = 0.9 or 1) the follicle size was significantly different. It appeared that above 
a barrier of approximately 1 kPa, the follicle growth was greatly inhibited. Fig. 2.3 shows 
the follicle morphology at the end of the culture period in gels with different stiffness. The 
follicles in the soft gels (r=0.8 and 0.9) had similar morphologies to in vivo graffian 
follicles; A big antrum cavity was observable. In the stiffer gels (r=1.0 and 1.2), no antrum 
formation but only granulosa cell layers was detectable. These results are in agreement with 
previous studies that demonstrated that the stiffness of the matrix effects the antrum 
formation during follicle growth [37, 73]. In vivo, when the size of the follicle reaches 200 
μm, fluid accumulates between the granulosa cell layers and starts to form the antrum 
cavity [61]. The follicle size is then multiplied by 3 to 5 when compared to two-layered 
secondary follicle [68]. Our observations are fitting with this model where flexibility of the 
microenvironment is required for the follicle to undergo fluid accumulation and antrum 
formation. A limit of 1 kPa can be proposed as the maximal elastic modulus that allows 
antrum formation.  
 
 
 
Fig. 2.2. The comparison of follicle size (bar) and 
swelling ratio (dash line) by changing stoichiometric 
ratio. The secondary follicles (100-120µm) were 
cultured in the PEG-hydrogel with different 
mechanical properties for 11 days. Average ± SD is 
shown. (***P <0.001 and *P<0.05). The size of 
follicles were significantly different between r= 0.9 
and 1 with identical swelling ratios.  
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Whether the limited growth in stiff gels is due to smaller mesh size (thus to lower nutrient 
and signaling factor transport [72, 74] or to the mechanical constraints is still in question. 
However the different follicle sizes observed in gels with identical swelling but different G’ 
(r = 0.9 and r =1) tend to prove that the limitation is due to the mechanical constraints.  
The quality of the oocytes was assessed by the ability to resume meiosis. The gels were 
digested by collagenase I for retrieving the follicles. After, the induction of the ovulation, 
cumulus-oocyte complexes were observed as it can be observed in vivo. The cumulus cells 
are made of granulosa cells adjacent to the oocyte following it after ovulation. This process 
is called cumulus expansion or mucification [68].  
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Fig. 2.3. Morphological differences between the follicles cultured in the 
PEG-hydrogel of different stochiometric ratios after 11 days.  
The r ratios are (a) 0.8 , (b) 0.9, (c) 1.0, and (d) 1.5(Scale bar, 100 µm) 
 
When follicles with diameters higher than 250 μm were ovulated, the collected oocytes had 
well expended cumulus cells (Data not shown). Their survival rate was assessed as well as 
their maturation quality. The retrieved oocytes from r = 0.9 hydrogels showed the highest 
rate of maturated oocyte (MII = 56 %). In stiff gels (G’ > 1 kPa), no MII oocyte (r = 1) or 
only 10 % (r = 1.5) MII oocytes were found (Fig. 2.4). The few oocytes collected from stiff 
gels had a squashed shape. The softest gel (r=0.8) produced only 20 % of MII oocytes even 
though the follicle size were large enough and formed antrum. There, the softest matrix 
seemed to allow the follicle to grow faster producing already degenerated oocyte after 11 
days of culture. When survival rates were compared, only 50 % of the oocytes from the 
very soft gels survived where the survival in the other condition was between 85 to 95%. 
The MMP degradation of the already very soft gels played probably a role in the reduced 
quality of the produced oocytes as well.  
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Fig. 2.4. Mature oocytes grown in the follicle 
cultured in different stiffness PEG-hydrogel. The 
significant different (*P <0.05) was demonstrated 
in MII oocytes in the PEG-hydrogel at 0.9 of r 
ratio. Average ± SD is shown. Elastic modulus 
influences the nuclear maturation. 
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In this study, the stiffness and swelling ratios of the used microenvironments had a 
measurable affect on the follicle growth and on the subsequent oocyte quality. Around 900 
Pa gels (r = 0.9) seemed to be the most relevant for follicle culture. These results confirm 
that the physical characteristics of the follicle microenvironment are potent regulators of 
the granulosa cells proliferation and thus of the oocyte maturation.  
2.3.3. RGD effects on the follicle development 
For studying the effect of RGD, the secondary follicles were cultured in PEG-hydrogel 
with or without RGD. Optimal elastic moduli for the PEG-hydrogel were used (r = 0.9). 
The stoichiometric ratios were adjusted to compensate for the RGD presence or absence. 
No significant differences in size of the follicles were observed between the studied groups 
indicating that the elastic moduli were not influenced by the presence of RGD (Data not 
shown). Fig. 2.5 shows the morphologies of the follicles during growth. At day 1, follicles 
cultured with RGD showed theca cells attached to the artificial ECM. At day 3, theca cells 
proliferated and surrounded the base membrane. The group without RGD did not show 
attachment however; the theca cells proliferated and grew normally. The final 
morphologies were not different between the two groups. Ovulation was induced and the 
retrieved oocytes were assessed for their ability to resume meiosis. Follicles from the 
hydrogel with RGD produced 53.2 % maturated oocytes in average where the follicles 
cultured without RGD produced only 39.5 % (Fig. 2.6.a). The impact on quality of RGD 
was monitored by inducing parthenogenesis and measuring the rate of the obtained two-cell 
embryos. Fig. 2.6.b shows the development rate of the obtained two-cell embryos from the 
follicles culture with or without RGD. The oocytes collected from the hydrogel with RGD 
reached the 2-cellembryo stage with higher frequency than the oocytes from non-RGD 
hydrogel (31 % vs 8.5 %, the difference is significant at p < 0.01). These results 
demonstrated that RGD-mediated cell attachment had a positive effect on oocyte quality.  
Fig. 2.5. Morphological details of follicles cultured in PEG-hydrogels with or without RGD. 
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Fig. 2.6. Maturation rates of oocytes (a) and 2 cell 
embryos development (b) from the follicle cultured in 
PEG-hydrogel with or without RGD (**P<0.01). 
Average ± SD is shown. The RGD effect on 
development of the oocytes to 2 cell embryos stages. 
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Ovarian follicles are surrounded by basal lamina. Recent studies reported that this basal 
lamina regulates granulosa cell functions [75-77]. Laminine, type IV collagen, fibronectin, 
heparin sulphate proteoglycans is contained in the ECM components of basal lamina [62]. 
Huet et al. (2001) [77] demonstrated that the presence of an RGD peptide increased the 
proliferation and attachment of granulosa cells and mimicked the effect of fibronectin and 
laminin when only granulosa cells were cultured on plates. Previous studies demonstrated 
that peptide containing RGD sequences improved the expression of LH receptors in porcine 
granulosa cells stimulated by FSH [78] and increased progesterone and estradiol secretions 
of murine granulosa cells [79]. In this study, the follicles cultured in the PEG-hydrogel with 
or without RGD were not different in terms of morphology and size. However, the oocytes 
maturation and quality showed interesting differences highlighting the beneficial effects of 
the RGD presence. When the granulosa cells cultured on the RGD coated plastic, they first 
attachment and then secreted their own ECM attachment proteins [67]. The no difference in 
follicle growth could be partially explained by the endogenous production of ECM protein. 
However, the differences in quality could be explained by the stimulating effect of RGD on 
estrogen and progesterone secretion of the granulosa cells as well as the LH receptors 
production. These results demonstrated that mimicking physically and chemically the 
ovarian ECM improved the quality and the quantity of the produced mature oocytes.  
2.4. Conclusion 
In this study, the PEG-hydrogel system was efficiently tailored to mimic the ovarian ECM 
for follicle culture. The development of the follicles was largely influenced by the stiffness 
of the microenvironment. Less than 1 kPa gels were identified as optimal. The RGD 
presence in the system was also associated with improved quality and higher two-cell 
embryos rates obtained form the cultured follicles.     
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Chapter III 
 
Effects of FSH and LH on 3‐D cultured murine 
ovarian follicles   
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3.1. Introduction 
The development of in vitro ovarian follicle culture systems provides not only the 
knowledge of ovarian physiology but also benefits to clinical applications such as infertility 
treatments and fertility preservation in cases such as oocyte-devastating cancer treatments.  
The follicle as a morphological and functional unit in the mammalian ovary is composed of 
the oocyte and its surrounding somatic cells (granulosa and theca cells). The oocyte growth 
and maturation is depended on the growth and development of follicle structure. The 
process of follicle development is called folliculogenesis. The earliest stage of the follicle is 
called primordial follicle. It has the oocyte in the center surrounded by a single layer of 
flattened granulosa cells. Once the follicle enters the growth phase, the granulosa cells 
shape change to cuboidal, at the stage called primary follicle. The follicles with granulosa 
cells more than two layers are called secondary follicle or preantral follicle. The theca cells 
differentiate and the zona pellucida is completely formed at this stage. When the follicles 
reach 200 µm in size, a fluid-filled space is formed between the granulosa cells layers. This 
stage is known as the early antral follicle. Then the antrum increases in size by the 
ovulation and is finally called a graffian follicle or a late antral follicle [2, 21, 26]. The 
granulosa cells proliferate and differentiate by maintaining cellular communication with the 
oocyte during the folliculogenesis. It is demonstrated that metabolic coupling occurs 
between the oocyte and the granulosa cells. The transfer of small molecules into the oocyte 
through gap junctions during the in vitro growth period is as a key factor for the support of 
the oocyte’s activities [80, 81]. Heterologous gap junctions are present between oocytes 
and granulosa cells before forming the zona pellucida [82]. After the zona pellucida 
formation, the contact between the oocyte and the granulosa cells is maintained though the 
emission of cytoplasmic processes that penetrate the zona pellucida and reach the oocyte 
[2]. Thus, the maintenance of communication paths is essential for the follicle development.  
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Another important factor for the follicle development is the presence of physiological 
concentration of gonadotropins [83]. The main gonadotropins are the follicle-stimulating 
hormone (FSH) and the luteinizing hormone (LH). FSH stimulates the antral follicle for 
further growth and differentiation [84]. It promotes the granulosa cell proliferation in 
secondary follicles and prevents atresia. FSH is also essential for steroid hormones 
production as it stimulates the aromatase enzyme activity (P450 aromatase) and promotes 
the synthesis of luteinizing hormone receptors (LHR) leading to the follicle antrum 
formation [85-87].  LH plays an essential role in the stimulation of the enzyme cascade 
responsible for androgen biosynthesis in the theca-interstitial cells. Thus LH is determinant 
for achieving the final differentiation of the granulosa cell that leads to the resumption of 
the meiotic maturation and to the ovulation [88].  
In the established in vitro follicle culture, the use of these two gonadotropins is still 
controversial. FSH plays an important role for the acquisition of the oocyte’s 
developmental competences. FSH is usually added to the secondary follicle culture medium 
in mice and in large mammals [5, 33, 89]. It has been demonstrated that FSH is required at 
the minimal concentration of 10 mIU/mL [90] or 100 mIU/mL [33]. Mitchell et al., [91] 
reported that the populations of ovulation were significantly decreased at 1000 mIU/mL 
when compared to conditions using 100 mIU/mL for secondary follicle in vitro culture. The 
LH is not an essential factor for the oocyte growth and maturation in vivo [92]. Thus, the 
usage of LH in vitro remains controversial. Cortvrindt et al., [93] demonstrated that a low 
amount of LH enhances the percentage of healthy follicle and impacts positively the oocyte 
production while Lee and colleagues (2007) [94] reported no effect of LH on follicle 
growth and oocyte maturation.  
These contradictory results could be explained by the used culture system which is different 
from the in vivo situation. Follicles attached on plastic dishes loose their three-dimensional 
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(3-D) structure during the culture. The cell-cell interactions between the oocyte and the 
granulosa cells or between the granulosa cells and other the granulosa cells (or theca cells) 
are highly disturbed in 2-D systems. This “disconnection” may lead to the different results 
observed in the literature because these interactions can interfere with the hormone balance 
or the steroid production[93]. This justifies the necessity of studying the effects of hormone 
or growth factor in 3-D culture systems, which are closer to the in vivo ovarian 
microenvironment.  
3.2. Materials and Method 
3.2.1. Animals  
Female F1 hybrid (C57BL/6 x CBA/caj) mice bred and housed in temperature-, lighting-, 
and humidity-controlled room and given food and water ad libidum. All animal 
experimental procedures were approved by the veterinary authorities of the canton de 
Vaud in accordance with the Swiss Academy of Medical Science (SAMS) and the Swiss 
Academy of Sciences (SCNAT) guidelines.  
3.2.2. Synthesis of PEG-VS and peptide precursors  
PEG vinyl sulfone (PEG-VS) was synthesized by adapting the previously published 
protocol [18]. Briefly, 15 g of 4-arm PEG-OH (Mw = 20 kDa, Shearwater polymer, 
Huntsville, AL) was dried by azeotropic distillation in toluene (VWR, Nyon, Switzerland) 
for 4 hr using a Dean-Stark. The dried PEG-OH was dissolved in 500 mL of 
dichloromethane (Fisher Scientific, Wohlen, Switzerland) and sodium hydride (Sigma-
Aldrich, Buchs, Switzerland) was added at 20-fold molar excess over OH-group of PEG. 
Then, divinyl sulfone (Fluka, Buchs, Switzerland) was added at a 50-fold molar excess 
over the OH groups. This reaction was carried out at room temperature under argon with 
constant stirring. After 3 days, the excess sodium hydride was neutralized by acetic acid 
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(Fluka, Buchs, Switzerland). The mixture was filtered over a filter cell cake and 
concentrated by rotary evaporation. The concentrated polymer was precipitated in ice-cold 
diethylether (Brunschwig, Basel, Switzerland) and filtered. This precipitation was repeated 
3 times. Finally, the product was dried under vacuum at room temperature for 3 days and 
the yield was 82 %. 1H NMR showed characteristic vinyl sulfone peaks at 6.1, 6.4, and 6.8 
ppm. The degree of end-group conversion was found to be 95 %. The polymer was stored 
under argon at -20 °C until used. The procedure was reviewed in detailed by Kraehenbuehl 
et al. [69].   
RGDSP peptide (Ac-GCGWGRGDSPG-NH2) was synthesized by solid phase peptide 
synthesis using an automated peptide synthesizer (Chemspeed, Augst, Switzerland). 
NovaSyn TGR resin (Merck Biosciences, Laeufelfingen, Switzerland) with a standard 
Fmoc chemistry were used. Purification was performed by mass-directed reverse phase-
C18 HPLC using a Water Autopurification System. Separation and collection of the 
samples were performed upon UV with broad wavelength detection (210-400 nm) (Water 
PDA 996 UV photodiode array) and mass directed software (Waters Masslynx software). 
Peptide sequences were confirmed by MALDI-TOF in the proteomics core facility of 
EPFL.  
The cross-linking peptide that contains a sequence sensitive to for MMP cleavage (Ac-
GCREGPQG ↓IWGQERCG-NH2) was obtained from Neosystm S.A. (Strasboug, France).  
3.2.3. Preparation the aliquots of PEG-hydrogel 
The PEG hydrogels were formed by Michael-type addition of thiol-containing peptides 
onto VS-functionalized PEG. First, the PEG-VS necessary for forming hydrogels was 
functionalized with arginine-glycine-aspartic acid (RGD) peptides (also by Michael-type 
addition). Thirty-nine µL of 10 % PEG hydrogel (in TBS pH 8) solution were mixed with 
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6 µL of a 400 µM RGDSP peptide solution (in H2O). The addition proceeded at room 
temperature for 30 min. The PEG functionalized with RGD solutions were stored in 
aliquots of 22.5 µL at -20 °C.  
3.2.4. Follicle isolation, seeding and culture 
Ovaries were collected from two-week old F1 female mice (C57BL/6 x CBA) after 
euthanasia by cervical dislocation. The collected ovaries were washed with HBSS (Hank’s 
buffered salt solution, Gibco-Invitrogen, Switzerland) and placed in L15 (Leibovitz 
medium, Gibco-Invitrogen, Switzerland) supplemented with 10 % heat-inactivated FBS 
(fetal bovine serum, Hyclone), 100 IU/mL penicillin and 100 µg/mL streptomycin (P/S). 
The ovaries were mechanically dissected using insulin syringe.  Only follicles with two 
layers of granulosa cells (100-120 µm) were collected using a mouth-operated 
micropipette [70]. The follicles were washed and kept in L15 washing droplets covered by 
paraffin oil (Vitrolife, Sweden).   
For the PEG-hydrogel culture system, 7.5 µl of culture medium was added to the PEG 
solution and then mixed with 12 µL of crosslinker. The crosslinker was diluted in 0.3 M of 
TEOA and the amounts were adjusted to meet a 0.9 stoichiometric ratio that produces an 
elastic modulus of 967.67 ± 202.74 Pa and a swelling value of 40.25 ± 2.72. The follicle 
were seeded in the above described hydrogel system. Six µL hydrogel drops, containing a 
unique follicle were formed. After curing, each of these gels was placed in a well of a 96 
wells-plate, 150 µL of culture medium was added. The follicles were cultured for 11 days. 
The culture medium consisted of α-minimal essential medium (α-MEM  with glutamax, 
Gibco) supplemented with 5 % FBS, ITS (5 µg/mL insulin, 5 µg/mL transferrin, 5 ng/mL 
selenite, Sigma, Buchs, Switzerland), 1 % of P/S, 100 mIU/mL of recombinant follicle 
stimulating hormone (rFSH, Organon, Switzerland). Next day, the medium was changed 
48 
 
completely with fresh medium. Every second day, half of the medium was replaced with 
fresh one.  
In the drop culture 2-D system, droplets of 10 µL of culture medium were placed on a 60 
mm culture dish and covered with 7 mL of paraffin oil (Vitrolife, Sweden). The retrieved 
secondary follicles were seeded into each droplet and the next day, 10 µL of medium was 
added into the each droplet. Every 2 days, the half of the medium was changed. The 
follicles were cultured for 9 days as found ideal by Lee et al. (2007) [28].  
3.2.5. The effect of FSH and LH 
Two main gonadotropins were studied for follicle culture in PEG-hydrogel. Generally, 
murine follicles in 2-D culture systems are cultured in droplets of medium as single cells. 
In this drop culture system, the droplets were covered with mineral oil for maintaining a 
spherical shape and preventing evaporation. The concentration of FSH is usually set to100 
mIU/mL [95]. However, as the follicle cultured in the presented PEG-hydrogel system 
could require different concentration of FSH, several concentrations were tested (1, 10, 100 
mIU/mL) and compared with the drop culture system.  
The follicles grown in the PEG-hydrogel system were cultured in three different conditions 
in terms of LH supply; (medium A) no addition of LH in the medium: no LH, (medium B) 
LH was added at the first day and till day 3. LH was added again only at day 8 and till the 
end of the culture. LH concentration was 10 mIU/mL, (medium C) LH (10 mIU/mL) was 
used during the entire culture period. All the conditions used the optimized follicle culture 
medium containing 100 mIU/mL of FSH.  
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3.2.6. Oocyte maturation and quality assessment  
For the PEG-hydrogel system, the oocytes meiotic competences were assessed by induced 
maturation after 11 days of culture. The grown follicles were retrieved from gels by 
incubating the gels in a 5 mg/mL collagenase I solution (Sigma, Buchs, Switzerland). The 
maturation medium were prepared with the half of the obtained culture medium from last 
day of follicle culture and the half of fresh culture medium not containing FSH but 5 
ng/mL of human epidermal growth factor (EGF, Roche, Basel, Switzerland) and 2.5 
IU/mL of human chorionic gonadatropin (HCG, Organon, Switzerland). The retrieved 
grown follicles from the gel were incubated at 37 °C for 18-20 hrs to induce the ovulation. 
For the drop culture, 10 µL of cultured medium were removed and added to 10 µL of 
maturation medium (10 ng/mL of EGF and  5 IU/mL of hCG in culture medium absent 
FSH). The follicles were incubated for 16-18 hr. After the induction of the ovulation, 
oocytes were removed from the cumulus oocyte complex or from the follicle by using a 
mouth-operated micropipette. The collected oocytes were washed in M2 medium (Sigma, 
Buchs, Switzerland) droplets and their state was assessed under stereomicroscope and 
characterized as DG (degenerated), GV (intact germinal vesicle), or GVBD (germinal 
vesicle breakdown) based on the presence or the absence of a germinal vesicle and MII 
(metaphase II, maturated oocyte) due to the presence of polar body.  
3.2.7. Statistic analysis 
The statistical analysis of the data was performed with the program OriginPro 8.0 
(Originlab corporation, MA, USA). Significances at p< 0.001, p<0.01 and p<0.05 (***, ** 
and * respectively) of the differences were tested with a T test.  
 
3.3. Results and discussion 
3.3.1. Optimization of FSH concentration for PEG-hydrogel based culture systems  
Two layered secondary follicles (100-120 µm) were cultured with different concentrations 
of FSH (1, 10, and 100 mIU/mL) either in PEG-hydrogel functionalized with RGD or in the 
droplet covered with mineral oil as a single cells culture. The survival rate of the follicles 
cultured in PEG-hydrogel was slightly decreased at 1 mIU/mL of FSH when compared to 
higher concentrations (Fig. 3.1a). 
 
   
 
Fig.3.1. Effect of FSH concentration on (a) the survival rate and (b) on the size of the 
follicles cultured in PEG-hydrogel (***P<0.001). Average ± SD is shown. Follicle size 
was increased by increasing the concentration of FSH.  
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 The size of the follicles cultured in PEG-hydrogel was measured after 11 days in culture. 
This trait seemed to be a linear function of the concentration of FSH in the studied 
conditions. Interestingly, follicles cultured in the lower concentration of FSH (1 mIU/mL) 
could not reach 200 µm of diameter (Fig. 3.1b). The retrieved oocytes from the follicle 
cultured in PEG-hydrogel or from the droplets with the different FSH concentration were 
assessed for the resumption of meiosis (Fig. 3.2).  
   
 
Fig.3.2. Effect of FSH concentration on the maturation of the oocytes and on the 
percentage of produced MII. (a) Follicle grown in PEG-hydrogel. (b) Follicle cultured 
in the 2-D drop culture system. Average ± SD is shown. Average ± SD is shown. The 
nuclear maturation is increased by increasing the concentration FSH.  
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Increasing the concentration of FSH increased the rate of MII oocytes in both of the culture 
systems. However, the oocytes from the drop culture with 1 mIU/mL of FSH did not have 
any matured oocyte and most of them were flatten and had squashed shapes. For some of 
the oocytes, the zona pellucida was also missing. Fig. 3.3 shows the morphological 
differences between the follicles grown PEG-hydrogels and in the drop culture system at 
different concentration of FSH. In the PEG-hydrogel system, the follicles cultured with the 
highest concentration of FSH (100 mI/mL) formed large antrum cavities while the follicle 
grown with only 1 mIU/mL of FSH remained small in size and their granulosa cells started 
to migrate away and to degenerate. In the drop culture, it was observed that increasing the 
concentration of FSH increased the proliferation of the granulosa cells. In vivo, granulosa 
cells proliferate during the follicle diameter increase. These cells differentiate then under 
the control of FSH [67]. FSH plays a key role in proliferation and differentiation of 
granulosa cells and thus in antral follicle formation [33, 90]. The FSH receptors (FSH-R) 
are mediating the FSH physiological effect on the folliculogenesis. They are only expressed 
in granulosa cells of the secondary follicle, not in the granulosa cells of the primary follicle 
[96, 97]. The production of cyclic adenosin monophosphate (cAMP), lactate or estradiol 
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was found dependent on FSH-R synthesis and playing an important role in the development 
of the follicle [34]. The results demonstrated that decreasing the concentration of FSH is 
more dramatic for follicles grown in drop culture for follicles that developed in the PEG-
hydrogel system. The granulosa cells in the drop culture system were significantly less 
proliferating and they migrated away from the oocytes. The lack of communication 
between the granulosa cells and the oocyte at lower amount of FSH (1mIU/ml) may 
prevent the oocyte maturation. Moreover, the oocytes grown in these conditions attached 
on the bottom and grew flat and had squashed shape because not enough granulosa cells 
were present for supporting them. The follicles in PEG-hydrogel showed a delay in the 
proliferation of granulosa cells when the FSH amount was low. It has been demonstrated 
that the FSH was involved in the production of the LH receptors [98]. FSH is also playing a 
role in the activity of aromatase, an enzyme of the P450 superfamily that aromatizes 
androgens, produces estrogens and thus prevents atresia [99]. The follicles cultured in 
PEG-hydrogels at the lowest concentration of FSH (1 mIU/mL) showed migration and 
degeneration of the granulosa cells. This phenomenon was probably related to the atresia 
due to the lack of FSH. During folliculogenesis, several follicles start to grow together and 
only one or few of them are ovulated. The non-ovulated follicles undergo atresia: a 
hormonally controlled apoptosis [23]. The atresia is caused by signaling cascade 
downstream of FSH during the follicle selection process [99]. It is suggested that sufficient 
FSH help the antral follicle to escape from atresia and reach the preovulatory follicle stage 
[23]. The presented results show that the lack of FSH induced the suppression of the 
proliferation of the granulosa cells and the follicular degeneration in the PEG-hydrogel 
culture system while in the 2-D culture system only the proliferation of the granulosa cells 
was impaired. However, in both systems, the optimal concentration of FSH for the follicle 
culture was found to be 100 mIU/mL. 
 
Fig.3.3. Morphological differences induced by the FSH concentration in both Hydrogel at 
11 days of culture, ( a) 1 mIU/ml b) 10 mIU/mL c) 100 mIU/mL of FSH) and drop culture 
at 9 days of culture ( d) 1 mIU/ml e) 10 mIU/mL f) 100 mIU/mL of FSH). The scale bar is 
00 μm. FSH induced granulosa cells proliferation and atresia due to low level of FSH was 
bserved only in hydrogel.  
1
o
 
  
3.3.2. Effect of LH on the follicle culture in PEG-hydrogels 
During extraction from the ovaries around 20 % of all retrieved follicles lost most of their 
associated theca cells. Fig. 3.4 shows the morphological differences induced by the addition 
of LH. The follicles with theca cells showed that these cells grew more in presence of LH 
than without LH at day 3. The growth of the follicles was not different between the group 
without LH (medium A) and the group with partial supply of LH (medium B). However, 
when the LH was added in the medium continuously, the size of the follicles was 
significantly decreased. A key role of LH is the stimulation of the enzyme responsible for 
androgen production and the initiation of the terminal differentiation of the granulosa cells 
[88, 93].  
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Fig.3.4. Morphological differences induced by LH supply strategies. Medium A was LH 
free. Medium B was supplemented with LH at day 1 to 3 and 8 to 11. Medium C had LH all 
along the culture period. The used concentration of LH was 10 mIU/ mL.  The scale bar is 
100 μm. LH terminated differentiation of granulosa cells in PEG-hydrogel culture system.  
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The results from the follicles grown in medium C support the above-described role of LH. 
It showed that the follicles stopped their growth and subsequently decreased the granulosa 
cells layers. The maturation rate was measured for all the oocytes grown in media A, B and 
C. The highest rate of MII oocytes was observed in the group cultured without LH. No MII 
oocytes were retrieved from the group where LH was added continuously (Fig. 3.5). When 
the follicles were cultured in the medium B, the percentage of maturated oocytes (MII) was 
decreased as the concentration of LH was increased (Fig. 3.6). The group treated with low 
concentration of LH produced the highest MII oocytes ratio (52. 7 %). This low 
concentration of LH did not induce a significant difference in terms of MII rates when 
compared with the group from which LH was absent. These results are different from the 
results of previous studies using 2-D in vitro systems. The necessity of LH during 
secondary follicle culture was always controversial. Cotvrindt, et al (1998) [93] 
demonstrated that the addition of low concentration of LH enhances the antral like-cavity 
formation and improves the oocyte’s meiotic maturation during secondary follicle in vitro 
culture. On the other hand, Lee et al. (2007) [94] reported that there were no significant 
effects of LH in in vitro follicle culture systems. Our results support the latest; in the 
presented conditions LH supply did not have any beneficial effect on the rate of MII of 
oocytes cultured in PEG-hydrogels. Moreover, when LH was continuously supplied during 
the culture, the differentiation of the granulosa cells was terminated. The main difference 
between the studies is due to the loss of the follicle 3-D structure after six days of culture 
and to the absence of most intra-ovarian and ‘extra-follicular’ cues.  This disconnection 
could potentially prevent the negative impact of LH. Conversely, the follicle culture in 
PEG-hydrogel (as a 3-D system) could maintain the follicle structure, thus the LH could be 
negatively effective on the follicle growth and the oocyte meiosis.  
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Fig.3.5. Comparison of the effects of LH supply on the 
oocyte maturation rate. Medium A was LH free. Medium 
B was supplemented with LH at day 1 to 3 and 8 to 11. 
Medium C had LH all along the culture period. The used 
concentration of LH was 10 mIU/ mL. Average ± SD is 
shown. LH has negative effects for nuclear maturation. 
 3.4. Conclusion 
The effects of FSH and LH on the follicle cultured in PEG-hydrogel were closer to the 
effects observed in vivo when compared to the effects observed in the standard 2-D culture 
system. The granulosa cells could proliferate and atresia could be prevented the by 
increasing the concentration of FSH. The addition of LH along all the culture period led to 
the termination of granulosa cells differentiation. The present results show that the follicle 
culture in PEG-hydrogel is ideal for studying the effects of growth factors and hormone 
signaling on the ovarian microenvironment.  
            
 
Fig.3.6. Effect of LH concentration on the maturation rate 
of the cultures oocytes. The follicles were cultured in 
PEG-hydrogel with different concentration of LH. The LH 
was added only at day 1 and then next day, the medium 
was refreshed with a half volume of culture medium free 
of LH till the end of culture period.   
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Chapter IV 
 
Production of recombinant KL proteins and 
their effects on ovarian tissue culture. 
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4.1. Introduction 
c-Kit ligand (KL) is a pleiotropic growth factor also known as steel factor, mast cell growth 
factor or stem cell factor [20]. KL binds a tyrosine kinase receptor on its target cells to 
trigger a further signaling cascade. It has been demonstrated that mutations in the c-kit gene 
(the white spotting locus, W) or in the Kit ligand gene (the steel locus, SI) produced mice 
with defective fertility and hematopoiesis [41].  There are many studies that suggest that the 
c-kit/KL interaction plays a role in primordial germ cells (PGC) survival, migration and 
proliferation and in follicle development [49, 100, 101]. The mRNA and the protein of both 
the soluble (KL-1) and the membrane-bound (KL-2) forms of KL were found expressed in 
mouse ovaries. Their expressions were detected in the granulosa cells of follicles at all 
stages of development and in the cumulus cells of antral follicle [48, 102]. The KL-1 and 
KL-2 forms are known to be differentially regulated. They are reported to play a role within 
the ovary, in the germ cells or in the follicle development [49]. Thomas et al. (2005) [103] 
demonstrated that the KL-1/KL-2 mRNA ratio is important for controlling oocyte growth. 
They reported that, under FSH-stimulating condition, a low KL-1/KL-2 mRNA ratio 
favored the growth of the oocyte. The presence of the soluble form of KL (KL-1) was 
demonstrated to favor the proteolysis and the down regulation of the membrane receptor (c-
Kit) whereas the presence of the membrane-bound form (KL-2) favored a more sustained c-
Kit signaling in myeloid cell lines [104]. 
The development of the cryopreservation of ovarian tissue aroused the interest in 
primordial follicles as a source material. Efficient use of primordial follicle could help the 
assisted reproduction of domestic animals and endangered species. It could also help 
women exposed to radiotherapy or chemotherapy to recover their fertility [101]. Thus it is 
important to better understand what are the mechanisms underlying the exit of the follicle 
from the resting pool and the following folliculogenesis. KL is considered as one of few 
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known factors to be involved in this process [49] even though its precise role remains 
unclear. It has been reported that the activation of the primordial follicles is prompted by 
KL during ovarian organ culture [51]. Yoshida et al. (1997) [50] demonstrated that the 
KL/c-Kit interaction is important for primordial follicle activation.  
However, little is known about the KL role in the activation of primordial follicles in in 
vitro culture system. This is partially due to the need of developing a new in vitro culture 
system where KL-2 (the membrane-bound form of KL) is tethered to physiologically 
compatible substrate to mediate a relevant biological answer. It is here required to create a 
microenvironment that allows the c-Kit signaling, as it was the case for other immobilized 
signaling factors such as notch [40]. Tailored PEG-hydrogel systems allowing the covalent 
immobilization of proteins by Michel type addition [19] or by enzymatic reaction [105] 
could be of good use for this purpose.  
In this study, three different constructs coding for recombinant extracellular domains of the 
KL were prepared: 1) extracellular domain only (KLs), 2) extracellular domain plus a 
substrate sequence for Factor XIIIa, (KLstg) and 3) extracellular domain plus a substrate 
sequence for Factor XIIIa plus an RCG tag for Michel type addition immobilization 
(KLstag). The purified proteins were immobilized onto PEG-hydrogels. This system served 
for culturing four days-old ovarian tissues. The activation of the primordial follicles was 
monitored across all the studied conditions. 
4.2. Materials and methods 
4.2.1. Animals  
Female F1 hybrid (C57BL/6 x CBA/caj) mice bred and housed in temperature-, lighting-, 
and humidity-controlled room and given food and water ad libidum. All animal 
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experimental procedures were approved by the veterinary authorities of the canton de 
Vaud in accordance with the Swiss Academy of Medical Science (SAMS) and the Swiss 
Academy of Sciences (SCNAT) guidelines.  
4.2.2. Polymerase chain reaction amplification (PCR) and sequence determination 
Total RNA form adult mouse ovaries were extracted by using the total RNA extraction kit 
(Invitrogen, Switzerland). The purity and the quality of the extracted totRNA were 
assessed with a Bio-nano chip (Bioanalyzer 2000, Agilent Technologies, Switzerland). The 
concentration of the totRNA was determined with Nano-drop (ND-1000, Witec AG, 
Switzerland) by reading the absorbance at 260 and 280 nm. The synthesis of cDNA was 
performed by using the Superscript™III First-strand reverse transcriptase. Briefly, 3 µg of 
total totRNA, 50 µM oligo(dT)20, 10 mM dNTP mix, 0.8 µl of DEPC-treated water in 10 
µL of total volume were denaturated at 65 °C for 5 min and then placed on ice. The first 
cDNA strand was obtained by adding 2 µL of a 10X RT buffer, 4 µl of 25 mM MgCl2, 2 
µL of 0.1 M DTT, 1 µL of RNaseOUT (40U/µL) and 1 µL of Superscript™III. The mix 
was incubated at 50 °C for 50 min. The reaction was stopped by rising the temperature to 
85 °C for 5 min. The reaction was then chilled on ice and 1 µL of RNase H was added. 
The degradation of the totRNA was performed at 37 °C for 20 min. A double brand cDNA 
was obtained by performing a PCR with 10 µM of both sense and antisense primers (Table 
4.1), 1/10 volume of 10 x PCR buffer, 20 mM of dNTPmix and 1 unit of pfx 50 DNA 
polymerase (Invitogen, Switzerland). After a denaturation phase of 5 min at 95°C, the 
amplification proceeded for 30 cycles with an elongation time of 1 min 30 sec. The PCR 
products for pKL (only the full length extracellular domain) and pKLs (full length 
extracellular domain including the signaling peptide sequence) were cloned into a pDrive 
cloning vector (Qiagen, Switzerland) according to the manufacturer recommendations. E. 
coli (strain DH5α) competent cells were transfected with the obtained plasmids. Positive 
clones were identified by PCR on single colonies. The PCR parameters for identifying the 
positive clones were identical to the parameters used for producing the cDNA. Positive 
colonies were cultured overnight in LB liquid medium. The plasmids containing the 
sequences were obtained with a miniprep extraction kit (Promega, city,Switzerland).  
Table 4.1. PCR primers used for generating the various KL constructs.  
 
 
 
To introduce the sequence corresponding to the tags NQEQVSPL+ RCG, synthetic and 
complementary single strand DNA fragments coding for the needed sequence were 
ordered from Mircrosynth (Geneva, Switzerland). Care was taken to ensure that the ends 
were compatible with BbsI and HincIII digested fragments. 
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Both strands were mixed (200 pmol/µL each), denaturated at 95 °C for 10 min and 
annealed at room temperature for 2 h. One µg of plasmid containing KL was digested with 
BbsI (5 U/ul) and HincIII (10 U/ul) in NEB buffer 2 (New England Biolabs, Ipswich, MA, 
USA). The digestion reaction was stopped by incubation 20 min at 65°C. The digestion 
products were separated on 1% w/v agarose gel in TEA. The band corresponding to the 
plasmid (~4 kb) was excised and purified with a gel extraction kit (Qiagen, Switzerland). 
The linerized plasmid and the synthetic DNA sequence were mixed (mole to mole) in 10 x 
ligase buffer. T4 ligase (1 ug /uL) was added to the mix and incubation at 4 °C proceeded 
overnight. The mix was used for transforming DH5α competent E. coli cells. Positive 
clones were identified as mentioned above. This procedure is described in Fig. 4.1.  
 
 
Fig.4.1. Cloning of the tag sequence into pKL vectors 
 
 
To sub-clone pKL and pKLs into pEF1mycHis mammalian expression vector (Invitorogen, 
Switzerland) special primers embedding KpnI or NotI cleavage sites at the 5’ ends and 
spanning over the desired sequence were designed. PCR products for pEFKLs, pEFKLstag, 
and pEFKLstg (Fig. 4.2) were generated and digested with KpnI and NotI to produce 
compatible ends with the expression vector. The linearized (KpnI and NotI) expression 
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plasmid and the digested PCR products were mixed (mole to mole) and ligated with T4 
DNA ligase (Promega, Switzerland). The plasmids were amplified in E. coli and 
maxipreps (Qiangen, Switzerland) were made to produce large quantities of the three KL 
expression vectors. 
 
 
Fig.4.2. Cloning of KL variant constructs: (a) wild type extracellular domain of KL, 
pEFKLs, (b) pEFKLstg, and (c) pEFKLstag.  
 
All the DNA quantifications were made with an ND-1000 spectrophotometer (Nanodrop, 
Witec AG, Switzerland). The sequence of all the obtained plasmids were controlled by 
sequencing (Microsynth, Geneva, Switzerland) and aligned versus the correct theoretical 
sequence using the Multalign software [106].  
4.2.4. Production of recombinant KL fusion proteins  
Suspension-adapted HEK-293 cells were routinely maintained in serum-free Ex-Cell 293 
medium (SAFC Biosciences, St. Louis, MO) with 4 mM glutamine as described [107].  On 
the day before transfection, cells were inoculated into fresh medium at a density of 1 x 106 
cells/ml.  The next day, the cells were harvested by centrifugation at 1,200 rpm for 5 min 
and resuspended at a density of 20 x 106 cells/ml in 200 ml of Ex-Cell 293 medium with 4 
mM glutamine in a 500-ml glass bottle [108].  Plasmid DNA and linear 25 kDa 
polyethylenimine (1 mg/ml in H2O; Polysciences, Eppenheim, Germany) were 
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sequentially added to concentrations of 25 μg/ml and 75 μg/ml, respectively.  The culture 
was agitated by orbital shaking at 110 rpm in an ISF-4-W incubator (Kühner AG, 
Birsfelden, Switzerland) at 37°C in the presence of 5% CO2.  The bottle cap remained 
open about one-quarter of a turn.  After 3 h the culture, the transfected cells were divided 
equally into two 5-liter glass bottles (Schott Glass, Mainz, Germany) each containing 1.9 l 
of prewarmed Pro293s medium (Lonza, Verviers, Belgium) with 4 mM glutamine. 
Valproic acid (500 mM in H2O) (SAFC Biosciences) was added to a final concentration of 
4 mM [109]. The two cultures were incubated with agitation as before.  At 7 d post-
transfection, the cell culture medium was recovered by centrifugation at 1,500 rpm for 10 
min. 
4.2.5. Purification and quantification of the expressed proteins 
Purification of the expressed protein was carried out by his-tag 
affinity chromatography on a Biorad Profinia (Biorad, Hercules, CA, 
USA) system with the Bio-Scale Mini Profinity IMAC cartridge with 5 mL 
column volume. The medium was filtered prior to purification with a 
low-binding 0.25 µm filter. 200 mL of the medium was injected into the 
column and the flow-through collected. Buffers of the native IMAC 
purification kit (Biorad, Switzerland) were used for all subsequent steps. After 
injecting, a washing step with two column volumes with 25 mM imidazole 
was performed of a 50 mM sodium phosphate buffer with 100 mM NaCl. 
Fractions were buffer exchanged sodium phosphate buffer on a Bio-Scale 
Mini Bio-Gel P-6 desalting cartridge. The first two fractions 
contained the protein according to the chromatogram. The flow-through, 
wash and elution fractions were analyzed by SDS-PAGE and the protein 
identity confirmed by LC-MS/MS and MALDI-TOF 
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The expressed proteins were quantified with a BCA protein assay by using a BCA protein 
assay kit (Perbio, Switzerland). ELISA was performed with an SCF Elisa kit (R & D 
system, UK).  
4.2.6. Immunodetection of the expressed and purified recombinant proteins 
The expressed proteins were analyzed by Western blot under both reducing and non-
reducing conditions. The samples were separated by SDS-PAGE and electrochemically 
transferred onto nitrocellulose membrane. Immuoblot analysis was carried out according to 
the protocol recommended by Bio-Rad. Rabbit polyclonal antibodies against mouse SCF 
(Abcam, Switzerland) were used as the primary antibody and horseradish peroxidase 
conjugated anti-rabbit IgG antibiody as the detecting reagent.  
4.2.7. Mass spectrometry analysis 
Samples were reduced-alkylated (DTE/Iodoacetamide) in order to maintain the disulfide 
bounds in the reduced form. Trypsin digestion was then performed for at least 12 hours at 
37 °C. Finally, resulting peptides were concentrated by Speed-Vac evaporation.  
Samples were resuspended in LC-MS starting solvent (2%ACN, 0.1%FA) for LC-MS 
measurement. Around 500 femtomoles were captured on a precolumn, desalted and 
separated on a C18 100μm x 10mm capillary column. MS measurements were performed 
on a LTQ linear ion trap (Thermo). A sub-database containing edited sequences of KL was 
used for the search (Fig. 4.3).  
4.2.8. Preparation of PEG-hydrogels functionalized with rKL proteins 
PEG vinyl-sulfone (PEG-VS) was synthesized by adapting previously published protocol 
[18]. The PEG hydrogels were formed by Michael-type addition of thiol-containing 
peptides onto VS-functionalized PEG. TG-lys peptide (Ac-FKGERCG-NH2) was 
synthesized by solid phase peptide synthesis using an automated peptide synthesizer 
(Chemspeed, Augst, Switzerland). NovaSyn TGR resin (Merck Biosciences, Laeufelfingen, 
Switzerland) with a standard Fmoc chemistry was used. Purification was performed by 
mass-directed reverse phase-C18 HPLC using a Water Autopurification System. Separation 
and collection of the samples were performed upon UV with broad wavelength detection 
(210-400 nm) (Water PDA 996 UV photodiode array) and mass directed software (Waters 
Masslynx software). Peptide sequences were confirmed by MALDI-TOF in the proteomics 
core facility of EPFL. The cross-linking peptide that contains a sequence sensitive to for 
MMP cleavage (Ac-GCREGPQG ↓IWGQERCG-NH2) was obtained from Neosystm S.A. 
(Strasboug, France).  
 
Fig.4.3. Alignment of KL sequences quality assessment in LC-MS 
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First, the PEG-VS necessary for forming hydrogels was functionalized with a substrate 
peptide for Factor XIIIa, Ac-FKGERCG-NH2 (named TG-lys, mol wt 837.4 g/mol) via 
Michael-type addition as well. Thirty-nine µL of 10 % PEG hydrogel (in Tris buffered 
saline, TBS pH 8) solution were mixed with 6 µL of TG-lys peptide solution (in H2O). 
The addition proceeded at room temperature for 30 min. The solutions of PEG 
functionalized with TG-lys were stored in aliquots of 22.5 µL at -20 °C. In a second time, 
the KLstg which had the factor XIIIa substrate sequence NQEQVSPL (TG-Gln), was 
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reacted with TG-lys bound to the PEG in the presence of the activated factor XIIIa [105]. 
For example, 100 µM of KLstg was mixed with 1 µL of TBS containing 100 µM of 
calcium chloride and 0.5 µL of activated factor XIIIa. The mixture was added to the 
prepared PEG aliquot and reacted for 30 min at room temperature.  Briefly, the activated 
factor XIIIa was prepared such that a 100 µL of the factor XIII (273 U/mL, a generous gift 
of Baxter Biosurgery, Vienna Austria) was activated with 10 µL of thrombin (200 U/mL, 
GEHealthcare, Switzerand) for 30 min at 37 °C. Small aliquots of activated factor XIIIa 
were stored at -80 °C.   
4.2.9. Immobilization assay of KLstg onto PEG hydrogel 
The binding assay was carried out with different concentration of KLstg recombinant 
protein. The functionalized with KLstg PEG-VS was cross-linked with the MMP sensitive 
peptide (0.3 M TEOA, pH 8.0) at 37 °C for 18 min. The obtained PEG hydrogels were 
placed into 150 µL of distilled water in a 96-well plate. After, the gels were incubated at 
37 °C for 3 days. The amount of KL protein that diffused out of the gels was quantified by 
performing an SCF ELISA kit assay (R&D system, UK) to detect the presence of the 
recombinant protein in the water.  
4.2.10. Mouse ovarian tissue culture in PEG-hydrogel 
The mouse ovaries were obtained from four-day old mice after scarifying by cervical 
displacement. The ovaries were moved in L-15 medium (Gibco, Switzerland) and tore, 
under a stereomicroscope, in100-200 µm size pieces with an insulin syringe. The prepared 
ovarian tissues were seeded into the mixture of the PEG solution containing diverse 
concentrations of KLstg protein or crosslinker. Hydrogel precursors were mixed and 
incubated at 37 °C for 18 min to gel. The formed PEG-hydrogel with embedded ovarian 
tissue were placed into 150 µL of MEM-α medium (Gibco, Switzerland) containing 100 x 
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ITS (Sigma, Switzerland), 1% P/S, 5 % FBS (Hyclone, Switzerland), and 100 mU/mL 
FSH (Organon, Switzerland). The medium was completely changed with fresh medium 
next day. Every two days, the half of medium was refreshed for 10 or 20 days.  
After 10 days, PEG-hydrogels were harvested by digesting the gels with collagenase I 
(Sigma, Swizerland). The obtained ovarian tissues were embedded in paraffin, sectioned (5 
µm sections), and stained with hematoxylin and eosin. The number of viable follicles was 
counted with an Olympus AX 70 upright monitored microscope (20X magnification).  
 
4.3. Results and discussion 
4.3.1. Cloning of rKL variant constructs 
Human KL is a protein that contains 273 amino acids divided into a signal sequence, an 
extracellular, a transmebrane and an intracellular domain. Murine and Human KL share 83% 
of sequence homology. It was demonstrated that murine KL efficiently replaces the Human 
one in activity tests performed on Human cells [100] (the opposite remaining not true). 
Thus the produced recombinant proteins could be used for future experiments with Human 
oocytes. The different constructs of KL contained the signal sequence (to allow the 
production in mammalian cells) and the extracellular domain. However they were different 
for the type of tags added to allow their immobilization onto PEG-hydrogels (Fig. 4.2). It is 
of interest to note that all of the recombinant KL included a thrombin cleavage site to allow 
the cleavage of the His tag used for the purification step. Two different KL constructs were 
designed to allow different strategies of immobilization onto PEG-hydrogel. One had only 
a substrate sequence for factor XIIIa, (NQEQVSPL), the other had both NQEQVSPL and 
RCG to allow a direct reaction with the vinylsulfone groups of the PEG via Michel type 
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addition. Transglutaminase (TG) is a family of enzyme that forms ε-(α-grutamyl) lysine 
isopeptide side-chain bridges by catalyzing an acyl-transfer reactions between the α-
carboxamide group of protein-bound glutaminyl (Gln, or Q) residues and the ε-amino 
group of lysyl (Lys, or K) residues [110].  An activated TG cross-linking enzyme; Factor 
XIIIa, plays a role in fibrin clot formation in damaged tissues [111]. We employed the 
Factor XIIIa substrate, the heptapeptide NQEQVSP named TG-Gln, for mobilizing KL 
onto the PEG-hydrogel. This sequence is derived from the N-terminus of the regulatory 
protein α2-plasmin inhibitor (α2PI). The full-length α2PI proteins are incorporated into 
fibrin networks during fibrinogen polymerization [112, 113]. Fig. 4.4 shows the scheme of 
PEG-hydrogel functionalized with KL by using the TG enzymatic cross-linking.  
The cDNA of KL was produced from the totRNA of adult mouse ovaries. The obtained 
RNA qualities and quantities are shown in Fig. 4.5. The peaks in the electropherogram 
show 18S and 28S RNA without noise and the gel represented both 18S and 28S. The 
rRNA ratio of the extracted RNA was 2.67. The RNA quality is assessed by the 28S to18S 
ribosomal RNA (rRNA) ratio.  Ratios higher than 2 indicates that the quality is satisfying 
[114]. Table 4.1 shows the primers used for the cloning of the different constructions of KL. 
Fig. 4.6 shows the amplification bands corresponding to pKL and β-actin as a control.  
4.3.2. Expressions and purification of rKL variants 
The structure of the extracellular domain of KL was proven to be stabilized with disulfide 
bonds [115]. Thus a reduction step was not possible during the purification process in order 
for the recombinant protein to retain its bioactivity. This consideration made the expression 
of the third KL (NQEQVSP+RCG) construct difficult as it adds an extra free cysteine to 
the sequence. Dimerization and loss of activity were then anticipated for that construct.  
The two other KL constructs were transfected on the HEK-293. Three and 0.6 mg of 
purified rKLs and rKLstg were respectively obtained.   
 
 
Fig.4.4. Scheme of PEG-hydrogel functionalization with KLtg. (a) Transglutaminase cross-
linking reaction. (b) PEG-hydrogel functionalized with TG-lys reacted with KLstg by TG 
reaction.  
 
 
4.3.3. Characterization of KL proteins 
The produced proteins, KL wild type extracellular domain (KLs) and KL with the TG-Gln 
sequence (KLstg) were found at the concentrations of 315.30 µg/mL and 60.08 µg/mL 
respectively in the culture media. SDS-PAGE and western blotting analysis showed that the 
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molecular weight of KLs and KLstg were of ~33 kDa under reducing and non-reducing 
conditions (Fig. 4.7). This indicates that both recombinant proteins were produced as 
monomers. KLs and KLstg were expected at 20856.7 and 21896.8 Da respectively. The 
observed higher molecular weight is certainly due to glycosylation. This post-translational 
modification was reported as critical for the biological activity of KL. Huang et al. 1992 
[116] reported the occurrence of four N-linked glycosylation site in KL. Natural and 
recombinant KL from chinese hamster was reported to be 30 % overweighed with 
carbohydrates [117, 118]. The glycosylated status did not block the binding of KL to c-Kit, 
even when the protein is heavily glycosylated [49]. The LC-MS analyzed peptides covered 
71 % of the sequence of both produced proteins (Fig. 4.8) confirming the efficiency of the 
production/purification method. 
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Fig. 4.5. The RNA extraction from mice ovaries. The quality and quantities were measured 
with Bio-nano chip. (a) ladder and (b) the extracted total RNA. The peaks in the 
electropherogram show 18S and 28S RNA without noise and the gel represented both 18S 
and 28S. The ribosomal RNA ratio is the extracted RNA was 2.67. 
 4.3.4. Immobilization of rKL onto the PEG-hydrogel 
Different concentrations of KLstg were bound onto the PEG-hydrogel as showed in the 
schemes of PEG-hydrogel formation (Fig. 4.4). The released KLstg from the hydrogels 
after 3 days of incubation were measured (Table 4.2). In all the conditions about 15 % of 
the immobilized KLstg was released. The results indicate that the amount of TG-lysin 
peptide bound on PEG was enough even for the high concentrations of KLstg. The non-
bound KLstg could be due to the short reaction time with the activated factor XIIIa or to the 
calcium concentration 
Fig. 4.6. Gel electrophoresis of PCR 
products. (a) Ladder, (b) β-actin, (C) 
pKL. The PCR products were loaded 
into a 1 % agarose gel in TEA.   
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Table 4.2. Immobilization assay of the KLstg. The releasing KLstg from the 
hydrogels after 3 days of incubation were measured by SCF Elisa kit. In all of the 
conditions about 15 % of KLstg were released from the hydrogel. 
  
 
 
Fig. 4.7.  The expressed rKL proteins were analyzed by (a) SDS-
PAGE and (b) western blotting. The 1 and 3 in western blotting are 
the non-reducing condition and 2 and 4 are the reducing condition. 
SDS-PAGE and western blotting analysis showed that the molecular 
weight of KLs and KLstag were of ∼ 33 kDa under reducing and 
non-reducing conditions.  
 
 
 
4.3.5. Ovarian tissue culture in the PEG-hydrogel system 
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Ovarian tissues from four days old mice were embedded in PEG-hydrogels functionalized 
with different concentration of KLstg and cultured for 10 days. The cultured ovarian tissues 
were compared to the condition supplied with 150 ng/mL of free KL in the medium. Fig. 
4.9 shows that visible primordial and primary follicles were seen in the fresh ovary 
collected from four days old mice. More primordial follicles were present on the cortical 
side of the ovary and only some of the primary follicles were in the center of the ovary. 
Thus, the best effort was made to tear the ovaries in homogeneous parts; all including the 
middle part of the ovary. After 10 days in culture, the follicle growth was assessed from the 
cultured ovarian tissues (Fig. 4.10). Secondary follicles were observed only in the 
conditions: “without KLstg” and “100 µM KLstg” and the number of secondary follicle 
was slightly higher in the “100 µM KLstg” condition (Table 4.3).  
 
Fig. 4.8. Mass spectrum of the generated KL peptides in LC-MS. The sequence coverage 
was 71% in the both produced proteins. It confirmed the efficiency of the 
production/purification method.  
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When the ovarian tissue was cultured with higher concentration of KLstg (300 µM), 
primary follicles were more present when compared with the other conditions. The 
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primordial follicles were present in the condition were soluble KL (KLs) was added to the 
medium. This result suggests that transmembrane form of KL can induce primordial 
development in 4 day-old mouse ovarian tissue. The observations suggest also that an 
optimal amount of the transmembrane form of KL is needed to activate the primordial 
follicles and allow the transition to the primary follicle state. However, due to the unknown 
initial number of primordial or primary follicle, it is difficult to comment on the rate of the 
primordial follicle activation induced by KL. Moreover, the sum of the visible number of 
oocytes in the dissected ovary was much smaller when compared to the number of oocytes 
found in a histological section of a four-day old mouse ovary. The activation of primordial 
follicle induces granulosa cell proliferation, morphogenesis and oocyte growth [49]. The 
granulosa cells in murine primordial follicle express only minimal amounts of KL mRNA 
and protein while the oocytes of primordial follicles express high amounts of c-Kit mRNA 
and proteins [20, 47]. This consideration rises the question of whether all of the oocytes in 
primordial follicle can be activated and resume growth by a KL stimulation? In vivo, 
primordial follicles are activated and exit the resting pool in a gradual manner [119]. 
However, it was observed in vitro that primordial follicles of species including cattle [120], 
primate [121], rat [51] and mouse [49] were spontaneously activated. Wandji et al. (1996) 
[120] proposed that this spontaneous activation was due to the absence of an inhibitor. 
Even though enough data are produced to assume that KL may have a role in primordial 
follicles activation and/or in promoting oocyte growth, it is still interesting to 1- elucidate 
how primordial follicles respond when over exposed to KL and to 2- define the respective 
roles of the soluble and membrane-bound in order to better understand KL signaling in the 
context of reproduction.   
 
 
Table 4.3. Number of visible in ovarian tissue cultured in PEG-hydrogel 
functionalized with KLstg. High concentration of KL in the hydrogel and soluble KL 
did not have any visible secondary follicles. 
 
4.4. Conclusion 
The three different constructions of KL (KLs, KLstg, and KLstag) were successfully cloned. 
KLs and KLstg were expressed in HEK-293 cells, purified and tested. Ovarian tissues from 
four-day old mice were cultured in PEG-hydrogels functionalized with KLstg and 
compared with the condition were soluble KLs was added to the medium.  The primordial 
follicles were activated and grew when they were cultured in the presence of immobilized 
KLstg but not when KL was suplyed under a soluble form. Further investigations using this 
platform will certainly be of help to better understand the respective roles of the membrane-
bound and the soluble form of KL during folliculogenesis. Further more, the established 
systems would be easily transferable for exploring the in vitro development of human 
ovarian follicles once the ethical clearance obtained. 
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Fig. 4.9. Histology section of the whole ovary 
from four-day old mice. 
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Fig. 10. Histology section of cultured ovarian tissues for 10 days in PEG-hydrogel 
functionalized with the different concentrations of KLstg. (a) no KLstg, (b) 100 μm 
of KLstg, (c) 300 μm of KLstg, and (d) 150 ng/mL of KLs was added in the 
medium.  
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Abstract 
Lymphatic vessels surround ovarian follicles, but the roles of lymphatics and 
lymphangiogenesis in folliculogenesis and pregnancy are undefined. Here we 
demonstrate a critical role for ovarian lymphatics in murine reproduction by blocking 
lymphangiogenesis with mF4-31C1, a specific antagonist antibody to vascular 
endothelial growth factor receptor (VEGFR)-3. VEGFR-3 neutralization for two weeks 
prior to mating blocked ovarian lymphangiogenesis throughout folliculogenesis 
without limiting blood angiogenesis. While the number of oocytes ovulated and 
fertilized and uterine implantations were normal, all pregnancies were unsuccessful 
due to fetal defects and miscarriage. Preantral follicles isolated from treated ovaries 
grew and matured normally in vitro. When embryos from mF4-31C1 treated mice were 
transferred to untreated surrogate mothers, pregnancies were normal and came to term. 
Conversely, normal embryos transferred to treated surrogate mothers led to the same 
fetal deficiencies as previously observed in situ, suggesting that lymphatic capillaries 
maintain an ovarian hormonal environment necessary for fetal development and 
pregnancy maintenance. Indeed, pregnant mice with blocked follicular 
lymphangiogenesis also exhibited significantly reduced progesterone and estradiol, 
hormones sourced from the ovarian corpora lutea during pregnancy. In total, these 
results demonstrate that lymphangiogenesis is a necessary process for ovarian 
lymphatic capillaries that transport hormones and thereby critical for successful 
reproduction. 
Keywords: corpus luteum, folliculogenesis, lymphatic, VEGF-C, VEGFR-3, blastocyst 
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5.1. Introduction 
Lymphatic vessels are present within the ovary and surround follicles during maturation 
[122, 123], but the importance of the lymphatic vasculature and lymphangiogenesis in the 
ovary is unclear. Consequently, the potential roles of lymphatic vessels in follicle 
maturation and pregnancy, and the extent or even necessity of lymphangiogenesis in 
reproduction, are undefined. This contrasts with ovarian blood angiogenesis, whose critical 
roles in follicular nourishment and maturation as well as the formation and maintenance of 
the corpus luteum is well appreciated; indeed, oocyte fertilization, embryonic implantation, 
and pregnancy all require blood angiogenesis [124-126]. Lymphangiogenesis, which is 
often concurrent with blood angiogenesis [127], may play an equally important role in 
these processes.  
Adult blood angiogenesis requires signaling via vascular endothelial growth factor (VEGF) 
receptor -2 (VEGFR-2), most potently by VEGF ligation [128, 129]. In murine ovaries, 
VEGF expression increases during angiogenic growth phases [130], and blockade of 
VEGFR-2 signaling effectively prevents angiogenesis, resulting in a marked decrease in 
ovarian weight, blood vessel density, number of corpora lutea, and infertility [131-133]. 
Since gonadatropin treatment apparently does not correct these deficiencies [134], it is 
likely that follicle maturation and successful pregnancy are highly dependent on VEGFR-2-
mediated neovascularization [124, 135]. 
VEGFR-3 is expressed primarily on lymphatic endothelial cells (LECs) in adult tissue [54, 
136], and its signaling, via ligation by VEGF-C or VEGF-D, is necessary for 
lymphangiogenesis by inducing LEC proliferation and migration [56, 57, 136, 137]. 
Blockade of VEGFR-3 signaling, using a function blocking antibody such as mF4-31C1 
(ImClone Systems), completely blocks the initiation of new lymphatic vessels in adult mice 
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without affecting pre-existing lymphatic morphology or function and without apparently 
affecting blood angiogenesis [56, 138]. Here we investigate the roles of lymphatic vessels 
and lymphangiogenesis in reproductive functions of the ovary. Specifically, we hypothesize 
that lymphangiogenesis within the ovary parallels blood angiogenesis during reproductive 
cycles [139-141] and that these new lymphatic capillaries may serve to balance hormones 
produced within the ovary, transport hormones from the ovary and corpus luteum, and aid 
in hormonal communication between the uterus and ovaries during pregnancy [142-144]. 
Using combined in vivo, ex vivo, and in vitro methods, we examined which aspects of 
fertility are influenced by inhibited lymphangiogenesis, including oocyte and follicular 
development and maturation, embryonic implantation in the uterus, and embryonic 
development. We show that blocking ovarian lymphangiogenesis prevents viable, full-term 
pregnancies due to decreased systemic hormone levels, thereby demonstrating a critical 
role for the ovarian lymphatic vasculature in reproduction. 
5.2. Materials and Methods 
5.2.1. Animal procedures 
All protocols were approved by the Veterinary Authorities of the Canton Vaud according to 
Swiss law (protocols 1687, 1988, and 1988.1). The function-blocking antibody against 
murine VEGFR-3, mF4-31C1, was kindly provided by ImClone Systems [57]. For two 
weeks prior to mating, 0.25 mL of 2.5 mg/mL mF4-31C1 was injected intraperitoneally 
every two days. 0.25 mL saline was similarly injected for some control groups with no 
adverse effects on reproductive potential. 
For studies without fertilization, 3 week old female F1 hybrid mice (C57Bl/6JxCBA/caj, 
Charles River Laboratories, France) were treated for two weeks and then sacrificed. 
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Follicles and ovaries were collected for subsequent in vitro culture and histological 
examination, respectively. 
In studies requiring fertilization, 4-6 week old female F1 hybrid (C57Bl/6JxCBA/caj) mice 
were treated for two weeks before mating (to ensure spanning two full menstrual cycles). 
At approximately 6-8 weeks of age, mice in estrus were mated and coitus was evaluated by 
the presence of a vaginal plug 16 hours post-mating. For embryo retrieval, ex vivo culture, 
and transplantation, mice were sacrificed 42 hours post-mating and two-cell embryos 
collected by oviduct flushing with M2 medium (Sigma-Aldrich, St. Louis, MO). 
Embryos were implanted into pseudo-pregnant recipient NMRI mice (Charles River) 
following standard implantation protocols. Embryos from mF4-31C1 treated and untreated 
F1 hybrid donors were implanted into treated and untreated recipients. Recipient mice were 
anesthetized using an intraperitoneal injection of ketamine (100mg/kg) and xylazine 
(10mg/kg). A small midsagittal incision, over each oviduct, was made and the donor 
embryos were deposited into each oviduct by mouth pipetting under a stereomicroscope. 
The incision was then sutured and pregnancies were permitted to continue through day 17. 
Implantation success was consistently >90%.  
For examination of fetal development and uterine implantation, mice were sacrificed at 
pregnancy day 17 or after birth. Implantation spots were counted in the uterus and fetuses 
were graded as either (a) normal, (b) grade i – normal sized but abnormal coloration, (c) 
grade ii –under-developed fetus (in size or limb development), and (d) grade iii – implanted 
cell mass or necrotic fetus (refer to Figure 5.2B for examples). 
5.2.2. In vitro follicle culture and maturation 
To determine the direct effects of in vivo mF4-31C1 treatment on normal follicle 
maturation potential, ovaries were isolated from 5-week-old mice following two weeks of 
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antibody treatment. In vitro maturation of preantral follicles was performed as previously 
described [3, 145]. Briefly, whole ovaries were placed in 3 mL of L-15 Leibovitz-glutamax 
medium (Gibco, Carlsbad, CA) with 10% FBS (HyClone Laboratories, Logan, UT) and 1% 
penicillin-streptomycin (Gibco) solution. Preantral follicles with diameters of 100-130 μm 
were mechanically separated from the ovaries, washed, transferred to individual 10 µL 
droplets of MEM-alpha-glutamax medium containing 5% FBS, 1% ITS (5 µg/mL, insulin, 
5 µg/mL, transferrin, and 5 µg/mL selenium mixture solution; all Gibco), 1% penicillin-
streptomycin, and 100 MIU/mL recombinant human follicle stimulating hormone (hFSH) 
(Organon, Switzerland).  
On day 12 of in vitro culture, follicle maturation was induced by exposing to medium 
lacking hFSH, but supplemented with 2.5 IU/mL hCG-Pregnyl (Organon) and 5 ng/mL 
murine epidermal growth factor (Sigma). After 16 hours, oocytes were retrieved by 
removing the follicular cumulus cells using 200 IU/mL of hyaluronidase (Sigma). Oocytes 
were classified by the following maturation states: germinal vesicle (GV), germinal vesicle 
breakdown (GVBD) and metaphase II (MII).  
In groups were VEGFR-3 was neutralized directly on normal follicles, follicles were 
cultured using the above reagents in a method modified from West, et al. [73]. 10 µg/mL 
mF4-31C1 was added to the culture medium of the test group. 
5.2.3 Ex vivo development of 2-cell embryos 
To determine the direct effects of VEGFR-3 inhibition on preimplantation embryonic 
development, two-cell embryos were retrieved from the oviducts and cultured in 4-well 
dishes containing 400 uL of M16 medium (Sigma). The number of embryos that developed 
into the 8-cell, morula, and blastocyst stages were quantified and imaged under a Nikon 
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SMZ1000 stereomicroscope with a Nikon DS-5M monochrome camera at 66, 90 and 114 
hours after mating, respectively. 
5.2.4 Immunofluorescence, immunohistochemistry, and histology 
To visualize lymphatic vessels, 6-μm-thick ovary and uterus cryosections were labeled with 
a primary antibody to the lymphatic-specific marker LYVE-1 (1:500; 07-538; Upstate, 
Charlottesville, VA). For blood vessels, ovaries were labeled with a FITC-conjugated 
primary antibody to CD31/PECAM-1 (1:200; 550274; BD Pharmingen, San Jose, CA). 
Vessels were also co-labeled for VEGFR-3 (1:100; AF743; R&D Systems, Minneapolis, 
MN). Sections were also labeled for the macrophage-specific surface marker F4/80 (1:50; 
MCA497; AbD Serotec, Oxford, UK) and collagen IV (1:1000, 10760; MP Biomedicals, 
Irvine, CA). These antibodies were detected with Alexafluor 488 or 594-conjugated donkey, 
rabbit, or goat IgG secondary antibodies (1:200, Molecular Probes) and nuclei were labeled 
with DAPI mounting medium (Vector Labs, Burlingame, CA). Fluorescent labeling was 
observed and imaged using a Zeiss Axiovert 200M microscope with a Zeiss MRm camera. 
Slides were then rinsed and counterstained with hematoxylin and eosin, dehydrated, 
mounted with Eukitt (Fluka Chemie, AG, Buchs, Switzerland), and imaged again using a 
color Zeiss MRc camera. The corresponding fluorescence and chromogenic images were 
then compared for identification, and subsequent quantification, of follicular development.  
To label apoptotic cells, a fluorescence TUNEL kit was used according to manufacturer’s 
instructions (Roche Diagnositics, Rotkreuz, Switzerland). Oil red O (Sigma-Aldrich, Buchs, 
Switzerland) was used to stain lipids in ovarian frozen sections. Sections were 
counterstained with hematoxylin and immediately mounted with Möwiol-based mounting 
medium for imaging. 
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5.2.5 Serum Analysis 
Serum was collected from all mice when sacrificed and analyzed using ELISA kits for 
estradiol (Calbiotech, Spring Valley, CA) and progesterone (BioSource, Carlsbad, CA) 
levels according to manufacturer’s instructions. Absorbance was measured using a Tecan 
Safire2 plate reader (Tecan, Männedorf, Swtizerland). 
5.2.6 Image analysis and quantification 
To quantify macrophages, Oil red O, and TUNEL labeled slides, images of entire ovaries 
were assembled, the ovary body was outlined, and the percentage of positive area measured 
using Metamorph 6.3 (Molecular Devices Corp., Sunnyvale, CA). For lymphatic and blood 
vessel quantification, we considered each follicular maturation state. Each follicle was 
outlined using a Wacom CintiQ freehand graphic monitor (Wacom Co., Ltd., Saitama, 
Japan) for accuracy. Vessel labeling was defined by fluorescence threshold and the number 
of positive pixels for each follicle was measured. The average vessel area for each 
maturation state is reported. Follicle maturation states were scored as follows: (i) preantral 
follicle (secondary follicle), (ii) antral follicle (small follicle with formed atrium), (iii) 
Graffian follicle (large follicle with significant atrium), and (iv) corpora lutea 
(Supplemental Figure 1). These divisions were consistently identified across multiple 
examiners. 
5.2.7 Statistical Methods 
For determining statistical significance between treatments in follicle vascularization over 
the stages of maturation, follicle survival and maturation, and embryo development, 
ANOVA followed by DUNCAN was used. Students’t-tests were used to compare other 
factors in treated vs. untreated plasma or in ovaries as a whole.  
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5.3. Results  
5.3.1 VEGFR-3 neutralization prevents successful murine pregnancy 
Female mice were mated at 6-8 weeks of age following 2 weeks of treatment with either (i) 
anti-VEGFR-3 neutralizing antibody (mF4-31C1), (ii) saline, or (iii) no injection (normal). 
All treatments were ceased before mating. Mice receiving saline or no injection were 
equally successful in giving birth to normal and healthy pups. Mice treated with mF4-31C1, 
however, failed to produce a single live birth in the animals tested. This unexpected 
response to VEGFR-3 blockade prior to mating led to the hypothesis that 
lymphangiogenesis within the ovary helps mediate reproductive ability. 
5.3.2 Ovarian lymphangiogenesis but not blood angiogenesis is inhibited by VEGFR-3 
blockade 
First, we examined blood and lymphatic vessels in the ovaries of saline-treated mice using 
CD31 and LYVE-1 co-labeling, and examined their relative expression of VEGFR-3. 
While all lymphatic (LYVE-1+) vessels expressed VEGFR-3 (Fig. 5.1A), limited VEGFR-3 
expression was found on follicular blood vessels (Fig. 5.1B). Lymphatic vessels were 
observed surrounding nearly every follicle at all maturation states and did not penetrate into 
the follicular body or thecal layers (Fig. 5.1A, C). The extent of lymphatic vascularization 
was dependent on the maturation stage of the follicles, with preantral follicles displaying 
only a few sparse lymphatics and corpora lutea displaying a significantly higher degree of 
peripheral lymphatic vessels. In ovaries from mice treated with mF4-31C1, the extent of 
lymphatic vascularization was greatly reduced at all stages of follicular maturation, as 
measured by vessel density (Fig. 5.1D). There was not, however, a complete lack of 
lymphatic vessels. This was consistent with our previous studies where VEGFR-3 
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neutralization prevented lymphangiogenesis but had no morphological effects on pre-
existing lymphatic vessels [56, 57].  
While mature blood vessels do not express VEGFR-3, angiogenic blood vessels have been 
observed to express VEGFR-3 during normal development as well as in tumors and healing 
wounds [146-148], and there is evidence that VEGFR-3 inhibition may limit tumor 
angiogenesis [60, 149]. Since blood angiogenesis in the ovary is necessary for pregnancy 
[124-126, 134, 150], we examined the blood vessels to assess whether mF4-31C1 had any 
effects on ovarian blood angiogenesis. We found VEGFR-3 expression primarily limited to 
lymphatic vessels, with the exception of the blood vasculature within the corpora lutea (Fig. 
5.1B). More importantly, the extent of blood vascularization, as quantified by vessel 
density, was not significantly affected by VEGFR-3 blockade (Fig. 5.1E). Therefore, 
ovarian blood angiogenesis appeared to be unaffected by VEGFR-3 neutralization, 
consistent with our findings in dermal wound healing and regeneration [56, 57].  
5.3.3 VEGFR-3 neutralization pre-fertilization leads to retarded embryonic development 
Since pregnancies were not successful in VEGFR-3 neutralized mice, we sought to 
determine at what stage post-fertilization observable differences could be seen in 
embryonic and fetal development. Mice were treated for two weeks and then mated, and 
the uteri examined at pregnancy day 17. We observed no differences in the number of 
implantation sites in the uteri of treated vs. control mice, but fewer fetuses remained in 
mF4-31C1-treated mice at pregnancy day 17 (Fig. 5.2A). More strikingly, those fetuses 
remaining were dramatically smaller and underdeveloped (Figs. 5.2A,B), threatening future 
miscarriage. Combined, these results indicate that multiple abortions had already occurred 
by day 17, and that the remaining fetuses were likely not viable. 
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To determine whether the numbers of ovulated oocytes were normal and to examine 
blastocyst development from VEGFR-3-blocked mice, mice were sacrificed 42 hr after 
mating and 2-cell embryos were flushed from the oviduct. The numbers of harvested 2-cell 
embryos per mouse were the same in normal vs treated mice, with an average of 7.1±2.5 
and 8.3±1.5 taken from normal and treated mice, respectively. Additionally, all 2-cell 
embryos were cultured in vitro to blastocysts with 100% success, regardless of treatment 
(Fig. 5.2C). Thus, although VEGFR-3 neutralization pre-maing dramatically affected 
embryonic development, it did not appear to reduce ovulation quantity or fertilization 
potential of ovulated oocytes.  
5.3.4 VEGFR-3 neutralization decreases number of healthy follicles but has no direct effect 
on their quality 
To explore the possible effects of VEGFR-3 signaling and lack of lymphatic vasculature on 
follicular maturation potential in virgin mice, preantral follicles (100-130 μm in size) were 
retrieved after 2 weeks of treatment. The numbers of healthy preantral follicles successfully 
retrieved was lower (P<0.01)  from  mF4‐31C1‐treated  mice  than  from  saline‐treated 
mice  (Fig.  5.3A).  This  was  due  to  a  noted  fragile  contact  between  the  oocyte  and 
granulosa  cells  in  mF4‐31C1  treated  mice  (noting  that  preantral  follicles  require 
interactions  between  surrounding  granulosa  and  theca  cell  layers  and  the  oocyte 
[145]). These contacts were apparently not, however, due to any loss of integrity of the 
basal lamina as examined by collagen IV staining (Fig. 5.3B), since no differences were 
observed in the granulosa-thecal boundary. While these discrepancies may impact the local 
hormonal environment in vivo, once separated and cultured in vitro, both groups of 
preantral follicles exhibited similar survival rates (P=0.763, Fig. 5.3C). Surviving follicles 
were able to mature normally, as defined by the method [3], through the GVBD and MII 
phase with equal success (Fig. 5.3C).  
90 
 
Finally, to determine whether VEGFR-3 blocking had any direct effects on folliculogenesis, 
we isolated preantral follicles from untreated mice and cultured them in the presence of 10 
μg/mL mF4-31C1 in vitro. All follicles survived (Fig. 5.3D) and grew to similar sizes 
(P=0.299, Fig. 5.3E). Thus, VEGFR-3 blocking had no direct effect on in vitro growth and 
maturation of secondary follicles. 
5.3.5 Loss of lymphatic capillaries does not alter macrophage recruitment, lipid 
accumulation, or apoptosis within the ovary 
Our combined in vivo and in vitro results suggest that failed pregnancies derive from 
alterations in the follicular environment due to the lack of lymphatic vessels. Since immune 
function may be important in mediating the balance between hormone accumulation [151] 
and follicle maturation and ovulation within the ovary [152, 153], and since lymphatic 
capillaries may be important in ovarian immune cell trafficking [139, 140], we examined 
macrophage populations in the ovaries (Fig. 5.4A). We found no significant differences in 
macrophage numbers within the ovaries (P=0.362; Fig. 5.4B). Therefore, the lack of 
lymphatic capillaries did not visibly alter overall macrophage recruitment in the ovary.  
Furthermore, lymphatic insufficiencies have been linked to excessive tissue lipid 
accumulation in skin [154, 155]. Since lipids are necessary for hormone synthesis by 
granulosa and luteal cells in the ovary [156, 157], we examined gross lipid content in the 
ovaries via oil red O staining (Fig. 5.4C), but no differences were observed between mF4-
31C1-treated and control animals (P=0.532; Fig. 5.4D). 
Finally, we sought to determine whether blocking VEGFR-3 would affect cellular 
apoptosis, which normally occurs within certain bodies of the ovary throughout the 
menstrual cycle [158]. Analysis of apoptotic cells revealed a similar distribution and 
number of TUNEL-positive cells within the ovary (Fig. 5.4F) in both groups. Consistent 
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with earlier findings [158, 159], apoptotic cells were confined primarily to the interior layer 
granulosum of regressing antral follicles, regressing corpora lutea, and post-ovulatory cells 
at the ovarian wall in both groups (Fig. 5.4E). Thus, neither the direct blockade of VEGFR-
3 nor the resultant lack of a significant lymphatic vasculature led to abnormal cell apoptosis 
in the ovary. 
5.3.6 Loss of ovarian lymphatics results in significantly reduced hormone levels during 
pregnancy 
With few other differences between ovaries from treated and untreated mice noted, we 
sought to determine whether the lack of ovarian lymphatics altered hormone levels during 
pregnancy. Serum collected from systemic circulation 42 hours after mating revealed no 
change in progesterone levels (Fig. 5.5A), but a significant decrease in estradiol levels (Fig. 
5.5B). As estradiol is sourced from the granulosa/luteal cells in the corpus luteum during 
pregnancy, and since mF4-31C1 treatment had the greatest effect on decreasing follicle-
associated lymphatic capillaries around the corpora lutea (Fig. 5.1D), these data suggest 
that ovarian lymphangiogenesis is critical for hormone transport and that decreased 
follicular lymphatics lead to decreased progesterone and estrogen transport, critical for 
maintaining pregnancy, from the ovary. These findings also support the hypothesis that 
intraovarian lymphatic capillaries are the entry point of ovarian sourced hormones to the 
systemic circulation [144]. 
As hormone secretion by the murine corpora lutea has also been linked to proper blood 
angiogenesis, we verified the blood vasculature of pregnant mouse ovaries at day 17. In 
both untreated and treated mice, the blood vasculature of the corpora lutea appeared normal 
(Fig. 5.5C) while the lymphatic vasculature surrounding these bodies in mF4-31C1 treated 
ovaries was notably deficient. 
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5.3.7 Reduced ovarian hormone production by recipient mothers results in poor fetal 
development and miscarriage of transplanted normal embryos 
Finally, to demonstrate an ovarian, and not uterine, cause to pregnancy failures, we isolated 
two-cell embryos from normal and treated mothers and implanted them into normal and 
treated pseudo-pregnant recipient mothers. Regardless of the treatment of the donor mother, 
transplantation of embryos into normal mothers resulted in normal implantation and fetal 
development with only normal, viable fetuses found in the uterus at day 17 (Fig. 5.6A). 
Conversely, the deficient ovarian hormone signaling demonstrated in treated recipient 
mothers led to retarded fetal development of implanted embryos (Fig. 6A). In fact, the 
developmental deficiencies observed (Fig. 5.6B) were nearly identical to those found 
during in situ pregnancies (Fig. 5.2A,B). This supports the hypothesis of early ovarian 
lymphangiogenesis being necessary for subsequent pregnancy success. 
Further verification of an ovarian source to failed pregnancies was found upon examination 
of the uterine blood and lymphatic vasculature from normal and treated mothers. No 
changes in the blood or lymphatic vessel network of the ovarian wall were noted in early 
pregnancy (Fig. 5.6D). This lack of differences in the uterine vasculature supported the 
findings of normal implantation rates, and reinforced that ovarian lymphangiogenesis is the 
likely process affecting hormone maintenance. 
 
5.4. Discussion 
Taken in total, these results demonstrate that ovarian lymphatics, particularly those that 
develop during folliculogenesis, are necessary for maintaining pregnancy by providing a 
conduit for hormone transport. We saw that blockade of VEGFR-3 effectively halted 
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lymphangiogenesis of maturing follicles within the ovary while not visibly affecting blood 
angiogenesis, macrophage recruitment, lipid accumulation, or overall cell apoptosis. In the 
absence of lymphangiogenesis, there were fewer patent secondary follicles, but those that 
were patent could mature normally, were ovulated, and could be fertilized. Embryonic 
masses naturally implanted in the uterus and partially developed, but all eventually 
miscarried; there were no successful births despite a normal number of uterine implantation 
spots. The absence of new lymphatics in the ovary appears mainly to disturb progesterone 
and estradiol levels during pregnancy. As these hormones are sourced from the copora lutea, 
it is likely the follicular lymphatic capillaries are necessary in regulating a hormonal 
environment conducive to normal pregnancy maintenance.  
The ovarian microvasculature is critical in regulating hormonal transport during pregnancy. 
Normally, as follicles mature, the theca layers become vascularized by blood vessels [160] 
and support follicles by synthesizing estrogen [161]; abnormalities in the theca cell layers 
can result in infertility [162]. Post-implantation, proper blood vascularization is necessary 
for successful pregnancy [124] and blocking blood vessel formation in the corpus luteum 
leads to pregnancy failures [126]. The developing blood vasculature of the corpus luteum 
permits this pseudo-organ to function properly, supplying increased progesterone and 
estrogen to the uterus to maintain pregnancy [126, 150, 163]. New lymphatic capillaries 
must supply a route by which hormones produced within the ovary enter systemic 
circulation [144]. Additionally, it has also been suggested that retrograde transfer of 
prostaglandin E2 – involved in many crucial processes of pregnancy, including 
maintenance of the corpora lutea - from the uterus to the ovary may occur via lymphatic 
transport [143, 150]. Indeed, our data demonstrates that ovarian lymphatic vessels and 
lymphangiogenesis are essential for reproduction. The poorly connected granulose of 
isolated follicles and lower levels of progesterone and estradiol during pregnancy are likely 
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related [164]. The blocked growth of lymphatic capillaries during folliculogenesis disturbs 
the hormonal balance, as evidenced by reduced estardiol with VEGFR-3 neutralization. The 
lymphatic vasculature of these follicles is then insufficient to modulate the copora lutea and 
their hormone secretions during pregnancy. As VEGFR-3 signaling, and therefore, 
lymphangiogenesis, was only blocked prior to mating, oocytes are ovulated and fertilized 
and embryos implant normally in the uterus, we have isolated a developmental period in 
which lymphangiogenesis appears to most critically occur.  
Another important role of lymphatic vasculature is to maintain fluid balance and interstitial 
fluid pressure (IFP). Throughout the body, these roles are inherently tied to lymphatic 
function. In the ovary, follicles become increasingly vascularized as they grow and a fluid-
filled antrum is formed. The IFP in antra of developing follicles is approximately 15 mmHg 
regardless of size and drops rapidly to 5mm Hg immediately preceding ovulation [165]. 
Post-ovulation, the IFP in the highly vascularized corpus luteum has been reported at a very 
high 50 mmHg [165]. Ovarian lymphatics clearly must play a role in modulating fluid 
pressures. Furthermore, concurrent lymphangiogenesis is likely necessary to drain 
extravasated fluid from the newly formed blood capillaries [140] and may help to regulate 
morphogenetic processes and signaling on the luteal cells by controlling interstitial flow, an 
important morphoregulator for many cell types [166]. 
Lack of ovarian lymphatics have also been reported in ADAMTS-1 knockout mice [122] 
and Frizzled4 knockout mice exhibit low levels of ovarian VEGF-C, the primary ligand to 
VEGFR-3 [167]. Both of these strains are infertile, despite normal mating behavior; 
infertility in these mice was concluded to be the result of failed hormone transport, 
intrafollicular pressure modulation, or maintenance of the corpus luteum. Mice possessing 
mutations in VEGFR-3 such that their lymphatic capillaries are present but poorly 
functional can reproduce, albeit at a lower success rate than wildtype mice [168, 169].  
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In conclusion, our data demonstrate that VEGFR-3-mediated lymphangiogenesis in the 
ovary is necessary for pregnancy by modulating levels of progesterone and estrogen from 
the corpora lutea. With anti-lymphangiogenic therapies aimed at preventing tumor 
metastases proposed as a cancer therapy [60, 149, 170] and pro-lymphangiogenic therapies 
proposed for treating lymphedema [168, 171, 172], it is critical to understand the role of 
lymphangiogenesis in the ovary and the role of lymphatics in fertility. Moreover, an 
increased knowledge of the physiologic role of lymphangiogenesis in the ovaries may 
provide insight into causes of infertility (and potential therapeutic strategies) and permit a 
more careful examination of vasculogenesis and lymphangiogenesis inherent with ovarian 
cancers. 
 Figures 
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Fig. 1. Ovarian and follicular lymphangiogenesis, but not blood angiogenesis, was inhibited by VEGFR‐3 
blockade in the ovary, preventing successful pregnancy. A) Ovarian lymphatic vessels (green, LYVE‐1) 
are VEGFR‐3 (red) positive (arrowheads). Some non‐lymphatic associated VEGFR‐3 is found on the 
blood vessels within the copora lutea (arrows). B) Blood vessels (green, CD31) are mostly negative for 
VEGFR‐3 (red), with the exception of those within the corpora lutea (arrow). As lymphatic vessels also 
express CD31, the strong VEGFR‐3 colocalization marks lymphatics (arrowheads). Bar=200μm. C) The 
extent of lymphatic vasculature (green, LYVE‐1) normally developing within the ovary, left, was 
reduced in VEGFR‐3 blocked ovaries, right; the blood vasculature (red, CD31) appeared to be 
unaffected by the treatment. Bar=200μm. D) Quantification of lymphatic vessel coverage in (i) 
preantral follicles, (ii) small follicles with formed atrium, (iii) large follicles with significant atrium and 
(iv) corpora lutea demonstrated the significant reduction in lymphatic vessels at each maturation state 
with VEGFR‐3 blockade. E) Blood vessel coverage was not affected by VEGFR‐3 blockade, despite some 
blood vessels expressing VEGFR‐3. Notice the normal increase in vascularization of the follicles with 
maturation for both lymphatic and blood vessels. *P<0.05 between treatments.  
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Fig. 2. Pregnancies occurred after lymphangiogenesis was blocked, but embryonic development was 
severely impaired in the womb. A) In mice treated with mF4‐31C1 prior to fertilization, few bodies 
remained within the uterus at pregnancy day 17, and they were scored as normal, (i) normal sized but 
discolored, (ii) deficient size and underdeveloped, and (iii) identifiable cell masses. B) Fetuses 
extracted at pregnancy day 17 from treated animals displayed a marked deficiency from control 
animals. Grid=4mm x 4mm. C) 2‐cell embryos were extracted from fertilized VEGFR‐3 treated mice and 
culture in vitro. The appearance of both 2‐cell embryos (left) and blastocysts (right) appeared identical 
to those taken from control animals. Scale bar=100μm. 
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Fig. 3. Secondary follicles, after being retrieved from the ovaries of treated mice, matured normally in 
vitro. A) Fewer patent follicles could be successfully separated from collected ovaries in treated mice. B) 
Patency was not determined by basal lamina quality, as collagen IV staining (green) displayed intact 
basement membranes (arrows) in both control and treated follicles. Bar=100μm. C) Follicles and their 
oocytes separated from ovaries of VEGFR‐3 treated mice survived normally in vitro. Surviving germinal 
vesicle (GV) oocytes from treated and control mice mature to germinal vesicle breakdown (GVBD) and 
metaphase II (MII) stages using the in vitro drop culture technique at equal rates. D) Survival of 
secondary follicles directly treated with the VEGFR‐3 blocking antibody in vitro was unihibited. E) 
Maturation potential, as determined by follicle size, was also unaffected by direct VEGFR‐3 treatment 
on the follicles. 
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Fig. 4. Macrophage recruitment, lipid accumulation, and cell apoptosis in the ovary appeared to be 
unaffected by VEGFR‐3 blockade. A) Macrophages (red, F4/80) present in the ovary was limited to 
follicular peripheries in both control and treated ovaries. Bar=100μm. B) The total number quantified 
within the ovary was unchanged. C) The ovaries contain large amount of lipids (red, Oil Red O), 
particularly in the copora lutea (arrowheads). Bar=300μm. D) Lipid accumulation in the ovary was not 
significantly different without lymphatics. E) Apoptotic cells (green, TUNEL) were limited to interior 
granulosa cells (arrows) of regressing follicles and regular apoptosis of regressing corpora lutea and 
corpus hemorrhagicum (arrowheads) in both treatments. Bar=100μm. F) No difference was measured 
in the number of apoptotic cells within the ovary with mF4‐31C1 treatment. 
  
Fig. 5. Blockade of lymphangiogenesis led to reduced systemic estradiol levels in mice following 
fertilization and decreases in both eastradiol and progesterone during pregnancy. A) Serum 
progesterone levels in control and mF4‐31C1 treated mice were normal at pregnancy day 2, but 
significantly reduced at pregnancy day 17. Since treatment was halted before mating, and since no 
difference was seen in serum levels at day 2, the mF4‐31C1 treatment did not directly affect these 
hormones. B) Estradiol levels were significantly reduced during pregnancy when ovarian 
lymphangiogenesis was blocked. *P<0.05 between treatments. C) The blood vasculature (red, CD31) 
corpora lutea in the ovaries of pregnant mothers at day 17 appeared normal in mF4‐31C1 treated mice. 
In control mothers, lymphatic vessels (arrows) (green, LYVE‐1) surround the corpus luteum and other 
follicles. Bar=200μm. 
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Fig. 6. All embryos – from both control and mF4‐31C1 treated mothers – implanted into treated 
recipient mothers were insufficiently developed despite normal uterine vasculature. A) 2‐cell embryos 
from saline and mF4‐31C1 treated mothers implanted into normal, pseudo‐pregnant recipient mothers 
developed into normal, viable fetuses by day 17. In pseudo‐pregnant mothers pre‐treated with mF4‐
31C1, embryos from control mothers failed to develop into normal fetuses, despite normal 
implantations. Grid=4mm. B) The distribution of fetal quality at day 17 following normal embryo 
transfer to mF4‐31C1 treated recipients closely replicated that of in situ fetal development, as reported 
in Figure 2. C) Blood (red, CD31) and lymphatic (green, LYVE‐1) capillaries in the uterine wall appeared 
normal in both mF4‐31C1 treated and untreated mothers, further supporting an ovarian cause. 
Bar=200μm. 
Supplemental Figure 1 
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Supplemental Figure 1. Follicular vasculature was calculated for four stages of 
follicle maturation. A) Follicles exist in various maturation states within the murine 
follicle with increasing vasculature with maturation. Follicles that had reached 
preantral status were identified for quantifying their surrounding vasculature. B) 
Each follicle was first identified and numbered on hematoxylin labeled sections, 
where follicular structure was easier to recognize. C) On the corresponding 
fluorescence image, each follicle was then outlined in Metamorph software (white 
lines indicate the concept) and the percent area of lymphatic and blood vessel 
coverage within each region of interest was quantified. Bars=200μm. 
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Chapter 6: Retrospective and outlooks 
 
The need for efficient follicles culture systems becomes obvious when the actual lack of a 
reliable source of mature oocytes is considered. The culture systems constitute also a key 
tool for the understanding of mechanisms such as oogenesis, folliculogenesis, and 
embryogenesis. Last two decades, a substantial effort was made to establish an efficient 
culture system and to acquire fundamental knowledge about the oocyte and follicle growth. 
The in vitro production of mature oocyte from primordial follicles was reported once in 
mouse [30]. The primordial follicles were fully maturated though a two-step culture, first 
neonatal ovarian organ culture and after preantral follicle culture. The produced oocytes 
could be fertilized and gave offspring. However, this technique was limited by a low yield 
and offspring plagued with multiple disorders such as premature aging. Although, the 
experiment could not be repeated, it brought the hope of an achievable growth and 
maturation of the oocyte in vitro.  
Most in vitro follicle culture systems are conventional 2-D culture system as extensively 
used in biology. The follicles in 2-D culture system remodel their structure in order to 
readapt to the hindrances caused by such an environment. This remodeling leads to 
disconnections between the oocyte and the granulosa cells or between the granulosa cells 
themselves. Despite a relative success in terms of secondary oocyte growth and maturation, 
the studies investigating the role of hormones or growth could hardly cope with such a bias 
and thus often reported contradictory results. The first introduced 3-D culture system used 
alginate bead and demonstrated that the structure of the follicles was maintained and that 
the oocyte maturation was possible. However, in this system it was difficult to observe the 
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morphology of the follicle during the culture because of the bead shape. This system was 
also limited by the possibility to load a unique follicle per bead. Moreover, functionalizing 
alginate with interesting growth factors was not straightforward. For overcoming these 
problems, a culture system based on tailored PEG-hydrogels is herein reported.  
In a first step, the mechanical properties of PEG-hydrogels could be tuned by varying the 
ratio of SV/TH thus modulating the crosslinks density of the hydrogel. The goal was to 
approach the mechanical properties of the ovarian tissue. The PEG-hydrogel systems was 
also functionalized with an integrin binding peptide (RGD) to mediate cell attachment as it 
could happen in environment where the ECM is present. Optimal conditions for oocyte 
growth, maturation and quality where established and compared with results obtained from 
2-D culture systems. Once these “basal” optimal conditions defined, the PEG-hydrogels 
culture system was used to study the effects of the most relevant gonadotropins for oocyte 
maturation (FSH and LH). This experiment intended to address the contradictory results 
published until now. The measured effects of LH and FSH in the PEG-hydrogels system 
were found to be relatively close to what is observer in vivo and drastically different from 
what is observed in the 2-D systems.  
This study highlights the importance of putting the studied material in a situation close to 
the in vivo microenvironment for investigating the effects of growth factor, hormones, 
drugs, etc.    
Better characterizing the function of the membrane-bound form of KL can potentially bring 
new insights in folliculogenesis and/or hemetopoiesis understandings. Here, the ease of 
signal immobilization onto the PEG-hydrogel can provide a valuable tool for studying such 
processes. In this context, various recombinant forms of KL (soluble and attached) were 
expressed in the mammalian cells. The tetherable form (KLstg) of KL was successfully 
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purified, tested and immobilized onto PEG-hydrogel. This system was used to culture 
ovarian tissues. After 10 days of culture, the results demonstrated that secondary follicles 
were only visible when a low amounts (100 µM) of KL was bond to the PEG matrix. Most 
primordial follicles did not develop when KL was present in a soluble form. The 
engineered forms of KL in combination with the PEG-hydrogel systems will certainly be of 
use to gain further knowledge in folliculogenesis and might serve to better understand 
hemetopoiesis as well. In addition, because of the cross-bioactivity of KL between mice 
and Humans, the reported platform could be of use for future clinical applications.  
In parallel, a new role for the lymphatic circulation in the modulation of hormone levels 
during pregnancy was identified. First, we have demonstrated that lymphangiogenesis 
occurs within the ovary during folliculogenesis and is essential for pregnancy. This is likely 
to modulate the systemic estrogen during pregnancy. Herein we proposed that the 
lymphatic circulation could influence the complex processes of folliculogenesis, ovulation, 
and pregnancy. Lymphatic vessels are critical in inflammation and fluid balance. The 
ovulation is considered to be a massive inflammatory event with the modulation of the 
pressure within the antrum of developed follicles, the massive secretion of hormones, and 
the eventual rupture of the ovarian capsule should present an almost unsustainable 
inflammatory environment. Lymphatic vessels should have the potential to modulate these 
factors as would occur in other tissues. However, further investigations are needed to assess 
the role of ovarian lymphatic capillaries in the views of examination of intrafollicular 
pressures, granulosa cell molecular expression, hormone secretion and hormonal rescue 
therapy. 
In this thesis, we demonstrate the potential of a tailored PEG-hydrogel system to study 
complex processes such as folliculogenesis. Breaking down the complexity of the 
microenvironment and reconstructing it in a combinatorial assay will certainly allow better 
106 
 
understanding of the key events governing events such as, activation, maturation and 
ovulation of the oocyte. In this context the PEG-hydrogels constitute an attractive platform 
because it combines advantages such dimensionality and relevant mechanical properties, 
cell responsiveness, ease of functionalization, compatibility with microscopic observation 
and single follicle analysis. Thus, it is safe to assume that that the efficiency of the PEG-
hydrogel system will be fully exploited when used in high throughput assays. This will 
certainly be of great use to the scientific community in its effort to bring innovative 
solutions to fertility-related questions.  
In a closer future it will be interesting to continue optimizing the system till embryonic 
development is obtained. In this context, continuing the investigations on the role of KL 
has the potential to yield valuable information. Other strategies such as genomic studies on 
cultured follicle can also be considered for identifying the remaining “bottlenecks”.   
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에필로그 
11 월 3 일 나의 생애 마지막 시험이 끝났다. 휴… 참 오랫동안 학교라는 울타리에서 학생이라는 
이름으로 살아왔다. 그리고 그 마침표를 드디어 찍은 것이다. 그 많았던 스트레스도, 이리 쉽게 
날아 갈 수 있단 말인가? 2004 년 난 유난히 등에 날개가 나는 듯한 느낌이 들었다. 꼭 어디든 훨훨 
날아 가야 갈 듯 했다. 이리저리 뛰어 다니며 비행 준비를 했다. 그렇게 처음 떠나온 곳이 취리히다. 
2004 년 7 월 29 일, 그 날을 잊을 수 있을까? 공항에서 취리히의 나의 기숙사로 오는 동안 택시 밖 
풍경은 작은 예쁜 마을이었다. 그리고 처음으로 집을 떠나서 살게 된 나의 기숙사 방은 너무 좋았다. 
나와 취리히의 첫 만남은 너무도 화창했다. 매주 토요일마다 난 취리히 시내 여기 저기를 다니고 
킨더스피탈(기숙사이름) 친구들과 가끔 산에도 가고 매일 저녁 같이 해 먹으면 즐거운 여름을 
보냈다. 그리고 다시 로잔이라는 곳으로 옮겨오면서 본격적인 학위에 들어 갔다. 첫 관문인 
박사과정 시험은 나를 많이 긴장시켰다. 열심히 준비한 결과, 시험은 무사히 아주 잘 통과했다. 그 
희망차고 야심만만한 과제를 수행하기 위해 동분서주하면 열심히 했다. 물론 난 그 과제를 내 
희망데로 완벽하게 해 내진 못 했다. 안 되는 것도 있다는 것을 배웠다. 아직 여러면에서 
부족하다는 것도 배웠다. 그러나, 끝낼 때는 끝내야 한다는 것, 방향을 돌릴 때는 돌려야 한다는 것, 
그리고 시작전에 많이 준비하고 해야한다는 것을 배웠다. 한국과 다른 인간 관계에 때문에 
힘들었다. 그러나, 이젠 알겠다. 어떻게 해야 하는 것이 좋을지. 이젠 모두와 어떻게 예쁘게 지낼 수 
있는지 알 것 같다.  
지난 5 년은 나에게 많은 변화를 준 아주 소중한 시간들이다. 빈 손으로 이곳엔 온 내가 지금은 너무 
많은 것을 가졌다. 결혼을 해서 사랑하는 남편, 사미가 있고 새로운 가족인 시집 식구들도 있고 늘 
날 지지해주고 자랑스러워 해 주고 우리 식구들 있다. 그리고 이제 3 주후면 나의 아들도 태어난다. 
이렇게 행복한 사람도 있을까?  이 모든 것에 정말 모두에게 감사드린다.  
앞으로 어떤 세상이 나에게 펼쳐질지 나두 참 궁금하다. 이제 나에 인생의 새로운 장으로 들어서는 
거다. 초심을 잃고 않고 늘 모든일에 최선을 다 하는 사람이 되었으면 한다.  
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